Uvienome Linda Sakor, N.P.; Decision and Order, 50173-50180 [2021-19194]
Download as PDF
Federal Register / Vol. 86, No. 170 / Tuesday, September 7, 2021 / Notices
In accordance with §§ 201.16(c) and
207.3 of the Commission’s rules, each
document filed by a party to the
investigations must be served on all
other parties to the investigations (as
identified by either the public or BPI
service list), and a certificate of service
must be timely filed. The Secretary will
not accept a document for filing without
a certificate of service.
Authority: These investigations are
being conducted under authority of title
VII of the Tariff Act of 1930; this notice
is published pursuant to § 207.21 of the
Commission’s rules.
By order of the Commission.
Issued: September 1, 2021.
Lisa Barton,
Secretary to the Commission.
[FR Doc. 2021–19316 Filed 9–3–21; 8:45 am]
BILLING CODE 7020–02–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Uvienome Linda Sakor, N.P.; Decision
and Order
sradovich on DSKJLST7X2PROD with NOTICES
I. Introduction
On June 19, 2019, the Assistant
Administrator, Diversion Control
Division, Drug Enforcement
Administration (hereinafter, DEA or
Government), issued an Order to Show
Cause (hereinafter, OSC) to Uvienome
Sakor, N.P., also known as Uvienome
Linda Sakor, N.P., (hereinafter,
Respondent) of Douglasville, Georgia.
OSC, at 1. The OSC proposed the
revocation of Respondent’s Certificate of
Registration No. MS1972101, the denial
of any pending applications for renewal
or modification of that registration, and
the denial of any applications for
additional DEA registrations for two
reasons. Id. First, it alleged that
Respondent ‘‘materially falsified
multiple renewal applications . . . filed
with the DEA.’’ Id. (citing 21 U.S.C.
824(a)(1)). Second, it alleged that
Respondent ‘‘pled guilty to a felony
relating to controlled substances.’’ OSC,
at 1 (citing 21 U.S.C. 824(a)(2)).
Specifically, the OSC alleged that
Respondent entered a guilty plea in
Georgia Superior Court to one count of
Forgery in the First Degree ‘‘for
attempting to fill a forged controlled
substance prescription.’’ OSC, at 2. This
OSC allegation acknowledged that,
under Georgia’s First Offender Act,
Respondent was discharged from
probation, was exonerated of any
criminal purpose, and is not considered
to have a criminal conviction. Id.
VerDate Sep<11>2014
00:30 Sep 04, 2021
Jkt 253001
Second, the OSC alleged that
Respondent entered into a Consent
Order with the Georgia Board of Nursing
(hereinafter, GBN) for her failure to
report her Forgery guilty plea as
required by Georgia statute. Id. It also
alleged that the Consent Order placed
Respondent on probation for two years.
Id.
Third, the OSC alleged that
Respondent submitted three materially
false registration renewal applications
after her guilty plea because she did not
respond affirmatively to the first
Liability question. Id. at 2–3. Similarly,
the OSC alleged that Respondent
submitted two materially false
registration renewal applications after
the beginning of the Consent Order’s
probationary period because she did not
respond affirmatively to the third
Liability question. Id. at 3.
Fourth, the OSC alleged that
Respondent’s guilty plea to the state
Forgery charge implicates 21 U.S.C.
824(a)(2). Id.
The OSC notified Respondent of the
right to request a hearing on the
allegations or to submit a written
statement, while waiving the right to a
hearing, the procedures for electing each
option, and the consequences for failing
to elect either option. Id. at 4 (citing 21
CFR 1301.43). The OSC also notified
Respondent of the opportunity to
submit a corrective action plan. OSC, at
4–5 (citing 21 U.S.C. 824(c)(2)(C)).
The Government forwarded its
Request for Final Agency Action
(hereinafter, RFAA), along with the
evidentiary record, to this office on
September 5, 2019. Attached to the
RFAA is the Declaration of a DEA
Diversion Investigator (hereinafter, DI)
that is signed and sworn to under
penalty of perjury. RFAA Exhibit
(hereinafter, RFAAX) 6 (Declaration of
Diversion Investigator, dated September
5, 2019 (hereinafter, DI Declaration)).
The DI Declaration states that the DI
‘‘personally served’’ the OSC on
Respondent at her registered location on
June 24, 2019. Id. at 3. I credit the DI’s
sworn statement.
Respondent waived her right to a
hearing and filed a written statement.
RFAAX 3 (Respondent’s Written
Statement, dated July 17, 2019
(hereinafter, Written Statement)), at 1.
Her Written Statement explicitly
references the OSC. Id.
Based on all of the evidence in the
record, I find that the Government’s
service of the OSC was legally
sufficient. In addition, based on all of
the evidence in the record, I find that
Respondent timely filed her Written
Statement. 21 CFR 1301.43.
PO 00000
Frm 00162
Fmt 4703
Sfmt 4703
U:\07SEN1.SGM
50173
I issue this Decision and Order based
on the Government’s submission, which
includes the Written Statement, and is
the entire record before me. 21 CFR
1301.43(e).
II. Findings of Fact
A. Respondent’s DEA Controlled
Substance Registration
Respondent is the holder of DEA
Certificate of Registration No.
MS1972101 at the registered address of
6559 Church St., Douglasville, GA
30134–1885. RFAAX 1 (Certification of
Registration History, dated September 4,
2019), at 1. Pursuant to this registration,
Respondent is authorized to dispense
controlled substances in schedules III
through V as a MLP-nurse
practitioner.1 Id. Respondent’s
registration expired on February 28,
2021, and is in an ‘‘active pending
status.’’ Id.
B. The Investigation of Respondent
According to the DI assigned to this
matter, ‘‘a large number of prescriptions
that had been issued by . . .
[Respondent] had been filled’’ at a
pharmacy the DI was investigating, and
Respondent is the sister of the
pharmacy’s owner. RFAAX 6, at 1. The
DI Declaration states that Respondent
‘‘previously had been convicted of a
felony involving forgery and that her
nursing license had been placed on
probation.’’ Id. According to the DI
Declaration, the DI’s investigation
included obtaining certified copies of
records of the Superior Court of Douglas
County and of the GBN. Id. at 2; see also
infra section II.C.
C. The Government’s Case
The Government’s case includes five
exhibits, one of which is the Written
Statement.
The first exhibit is the Certification of
Registration History. RFAAX 1.
According to that Certification,
Respondent submitted to the Agency
registration renewal applications on
December 31, 2011, February 25, 2015,
and January 5, 2018. Id. at 1. On each
of the three submissions, the
Certification of Registration History
states, Respondent answered ‘‘No’’ to
whether she ‘‘has . . . ever been
convicted of a crime in connection with
controlled substance(s) under state or
federal law, . . . or any such action
pending.’’ Id. at 1–2, 4, 7, 10. Further,
on each of the three submissions,
according to the Certification of
Registration History, Respondent
answered ‘‘No’’ to whether she ‘‘has
1 MLP means Mid-Level Practitioner. 21 CFR
1300.01(b).
07SEN1
50174
Federal Register / Vol. 86, No. 170 / Tuesday, September 7, 2021 / Notices
sradovich on DSKJLST7X2PROD with NOTICES
. . . ever surrendered (for cause) or had
a state professional license or controlled
substance registration revoked,
suspended, denied, restricted, or placed
on probation, or is any such action
pending.’’ Id. at 2, 4, 7, 10.
The next exhibit is the OSC, RFAAX
2, and the third exhibit is the Written
Statement, RFAAX 3.
The next exhibit consists of ten
documents certified by the ‘‘Clerk
Superior/State Court’’ as true and
correct copies from case ‘‘10CR00980
State of Georgia vs. Linda U. Sakor.’’ 2
RFAAX 4, at 1; see also RFAAX 6, at 2.
The first document is one page
consisting of the ‘‘Petition for Discharge
of Defendant (First Offender Act)’’ and
the signed ‘‘Order of Discharge,’’ dated
March 20, 2012. RFAAX 4, at 2. In this
document, a probation officer states that
Respondent is ‘‘eligible for discharge as
shown by having fulfilled the term of
. . . probation and upon review of . . .
[her] criminal record.’’ Id. Below the
probation officer’s statement, the Court’s
signed Order of Discharge states that (1)
Respondent is ‘‘discharged without
Court adjudication of guilt,’’ (2) the
‘‘discharge shall completely exonerate
. . . [Respondent] of any criminal
purpose,’’ (3) the ‘‘discharge shall not
affect any of . . . [Respondent’s] civil
rights or liberties,’’ (4) Respondent
‘‘shall not be considered to have a
criminal conviction,’’ and (5) the
‘‘discharge may not be used to
disqualify a person in any application
for employment or appointment to
office in either the public or private
sector by reason of criminal conviction
. . . unless otherwise provided by law.’’
Id.
The second document, consisting of
fifteen pages, is the ‘‘Transcript of
Proceedings’’ of the criminal hearing on
November 18, 2010. Id. at 3–17. The
Transcript states that Respondent was
present with her attorney ‘‘to enter a
negotiated guilty plea.’’ Id. at 4.
According to the Assistant District
Attorney (hereinafter, ADA),
Respondent changed employers in July
of 2008. Early in 2009, the ADA stated,
Respondent presented a prescription for
hydrocodone, purportedly issued by her
previous employer, to be filled at a
pharmacy. Id. at 9. The ADA indicated
that Respondent had forged the
2 Although the certification for RFAAX 4
references ‘‘Linda U. Sakor,’’ five of the documents
in RFAAX 4 refer to ‘‘Uvienome Linda Sakor,’’ three
of the documents refer to ‘‘Linda Sakor,’’ one
document refers to ‘‘Linda U. Sakor,’’ and one
document does not refer to anyone by name.
RFAAX 4, at 2 (Linda U. Sakor); id. at 3–26
(Uvienome Linda Sakor); id. at 27–30 (Linda Sakor);
id. at 31 (no name). I find substantial record
evidence that all of the documents in RFAAX 4
pertain to Respondent.
VerDate Sep<11>2014
00:30 Sep 04, 2021
Jkt 253001
prescription in the name of her previous
employer. Id. at 10. He also stated that
‘‘[t]here’s no evidence that there were
any other forged prescriptions
presented’’ by Respondent. Id.; see infra
section II.E. Respondent’s Public
Defender added that Respondent had
‘‘retained the [prescription] pad after
she had left their employ and basically
she wrote prescriptions out for herself
which basically she would have to have
gone back to the doctor to get that
authorized prior to the time this was
done and that’s not the way it was
done.’’ RFAAX 4, at 13 [emphasis
added]; see infra section II.E.
When the Court invited her to speak,
Respondent stated that ‘‘nurse
practitioners actually do have the
authority and . . . [she has] the
authority, . . . [has] the license to write
prescriptions for people in the State of
Georgia as in many other states, and that
is part of . . . [her] job.’’ RFAAX 4, at
14–15. She did not mention the
controlled substance schedule
parameters, schedules III through V, of
her federal authority to issue controlled
substance prescriptions. She finished by
stating that she ‘‘did the wrong thing in
writing it for . . . [her]self.’’ Id. at 15.
When the Court asked her why she
forged the prescription, she stated that
she ‘‘was having severe pain and could
not make it to . . . [her] doctor’s office.’’
Id. When the Court asked her, she
denied having ‘‘any sort of drug abuse
problem.’’ Id. The Transcript ends with
the Court imposing the recommended
sentence and treating Respondent as a
first offender. Id. at 15–16.
The third document is the one-page
Plea Sheet filed on November 18, 2010.
Id. at 18. The Plea Sheet shows that
Respondent pled guilty to one count,
that she was to undergo substance abuse
counseling, that she was fined $1,000,
and that she received a sentence of five
years’ probation with the possibility of
four years being suspended ‘‘after
completion of 1st year of probation
successfully.’’ Id.
The fourth document is the one-page
Waiver of Rights, dated November 18,
2010. Id. at 19. This document, signed
by Respondent and her attorney, lists
the rights that Respondent waived by
pleading guilty. Id. Over the Court’s
signature, the document states that
‘‘inquiry has been made of the . . .
[Respondent] concerning the rights
listed,’’ that the Court is ‘‘satisfied there
is an adequate factual basis to support
the guilty plea,’’ and that the Court is
satisfied that Respondent ‘‘is acting
knowingly, freely and voluntarily and
no promise, threat or force has been
used to induce the . . . [Respondent] to
enter this plea.’’ Id.
PO 00000
Frm 00163
Fmt 4703
Sfmt 4703
U:\07SEN1.SGM
The document comprising the next
three pages is the ‘‘First Offender
Treatment Order,’’ the ‘‘General
Conditions of Probation,’’ and the
‘‘Special Conditions of Probation
Imposed Pursuant to Code 42–8–34.1,’’
dated November 18, 2010. Id. at 20–22.
This document shows that Respondent
‘‘negotiated’’ a guilty plea to one count
and was sentenced to five years, which
may be served on probation, and the
payment of a $1,000 fine. Id. at 20–21.
The sixth set of documents concerns
the ‘‘Felony Accusation’’ about
Respondent. Id. at 23–26. The
documents indicate that Respondent
pled guilty to one count of ‘‘Forgery in
the First Degree (O.C.G.A. 16–9–1)’’ on
November 18, 2010. Id. at 23, 24, and
26. Her attorney and the ADA signed the
fully completed document along with
Respondent. Id. at 26.
The next two documents, ‘‘Entry of
Appearance; and Notice of Intent to
Engage in Reciprocal Discovery’’ and
‘‘Rule 5.2(2) Certificate of Service of
Discovery,’’ dated April 24, 2010, show
that Respondent was represented by
counsel at the proceedings. Id. at 27–28.
These documents also show two
‘‘unindicted’’ case numbers. Id.
The ninth document is the two-page
‘‘Affidavit for Arrest’’ concerning
Respondent, signed by a Douglas
County Magistrate Judge on March 30,
2010. Id. at 29–30. The first page shows
a warrant in the matter of ‘‘The State of
GA vs. [Respondent]’’ charging four
counts of Forgery, a Felony in the First
Degree, with bail set at $16,000. Id. at
29. The second page of the ‘‘Affidavit
for Arrest’’ shows a warrant in the
matter of ‘‘The State of GA vs.
[Respondent]’’ charging one count,
Theft by Taking, a misdemeanor, with
bail set at $1,000. Id. at 30.
The tenth and final document is
entitled ‘‘Arrest Warrant, County of
Douglas, State of Georgia, Exhibit: A
page 1 of 1’’ to the Forgery in the First
Degree ‘‘Affidavit for Arrest,’’ filed on
April 2010.3 Id. at 31. The ‘‘Arrest
Warrant’’ describes four counts of
Forgery in the First Degree. The first
count concerns the ‘‘knowing,’’ ‘‘with
intent to defraud’’ making of a ‘‘certain
writing in such a manner that the
writing as made purports to have been
made by authority of one . . . who did
not give such authority at another time
and did deliver said writing being a
prescription for Hydrocodon [sic] and
Phenergan.’’ Id. The other three counts
specifically concern the delivery to a
pharmacy of forged prescriptions for
Vicodin and Phenergan on September 8,
2009, Tussionex Pennkinetic on
3 The
day in April is not legible. RFAAX 4, at 31.
07SEN1
Federal Register / Vol. 86, No. 170 / Tuesday, September 7, 2021 / Notices
November 6, 2009, and Vicodin,
Ibuprofin, and Phenergan on November
11, 2009. Id.
The first page of the next exhibit is
the Certification of the GBN, dated July
23, 2019, concerning its Consent Order
with Respondent and the statement that
‘‘Respondent has met the terms and
conditions outlined in this order.’’
RFAAX 5, at 1. The second page is the
GBN letter to Respondent, dated July 20,
2015, advising Respondent that her
‘‘license is unencumbered and free of
the conditions imposed by’’ the Consent
Order. Id. at 2.
The remaining ten pages of RFAAX 5
is the June 25, 2013 Consent Order
between Respondent and the GBN. Id. at
3–11. The first page of the Consent
Order states that Respondent pled
guilty, ‘‘[o]n or about November 18,
2010,’’ to the ‘‘felony criminal offense of
Forgery, First Degree in the Superior
Court of Douglas County.’’ Id. at 3. It
also states that ‘‘Respondent failed to
report her felony conviction to the
Board within ten (10) days of such
conviction as required’’ by Georgia
statute. Id. Page three of the Consent
Order states that, ‘‘[u]pon the effective
date of this Consent Order, the
Respondent’s license to practice as a
registered professional nurse and
authorization to practice as an advanced
practice nurse in the State of Georgia
shall be placed on probation for a period
of two (2) years, or until lifted by the
Board.’’ Id. at 5. The Consent Order
specifies that ‘‘this Consent Order, once
approved and docketed, shall constitute
a public record, evidencing disciplinary
action by the Board.’’ Id. at 10. The
Consent order was approved on June 20,
2013, and docketed on June 25, 2013. Id.
at 10, 3.
The last exhibit of the RFAA is the DI
Declaration. RFAAX 6. In addition to
certifying some of the Government’s
other exhibits and providing the origins
of the investigation leading to the OSC,
as already discussed, the DI Declaration
affirms that Respondent pled guilty to
one felony count ‘‘for attempting to fill
a forged controlled substance
prescription’’ and ‘‘agreed [with the
GBN], among other things, to be placed
on probation for a period of two (2)
years.’’ Id. at 2.
sradovich on DSKJLST7X2PROD with NOTICES
D. Respondent’s Case
As already discussed, Respondent
submitted a timely Written Statement.
Supra section I. In her Written
Statement, Respondent stated that she
was responding to the ‘‘material
falsification of renewal applications for
. . . [her] DEA license’’ by ‘‘writ[ing] a
VerDate Sep<11>2014
00:30 Sep 04, 2021
Jkt 253001
statement of explanation.’’ 4 RFAAX 3,
at 1. Respondent began the explanation
by stating that ‘‘[i]n the year 2008, . . .
[she] made a very grave mistake which
. . . [she] will forever regret.’’ Id. She
elaborated, stating that she ‘‘wrote a
prescription for . . . [her]self in 2008 on
a prescription pad which belonged to
. . . [her] collaborating physician.’’ Id.
The prescription, according to her
Written Statement, ‘‘was for Vicodin
which is also known as Hydrocodone 5/
500 mg.’’ Id. She ‘‘did this,’’ she stated,
‘‘because . . . [she] was in severe
menstrual pain and could not make it to
see . . . [her] personal physician to
prescribe this medication for . . .
[her].’’ Id. Respondent wrote that she
‘‘presented this prescription to a local
pharmacy who notified the physician
. . . [she] worked with, and then
proceeded to notify the local
authorities.’’ Id. She stated that ‘‘[s]ince
then . . . [she has] undergone a lot of
emotional stress regarding the risk . . .
[she] placed . . . [her] career in.’’ Id.
According to her Written Statement,
she pleaded nolo contendere and ‘‘was
sentenced under the first offender act
[sic] and upon completion of . . . [her]
one-year probation was noted not to
have a felony conviction.’’ Id. ‘‘It was
based on this understanding,’’
Respondent wrote, ‘‘that . . . [she]
responded to the questions in . . . [her]
subsequent DEA renewal applications.’’
Id. Specifically, she admitted that ‘‘[i]n
December of 2011 on . . . [her] DEA
renewal application, . . . [she]
responded ‘No’ to liability question 1
with the understanding that . . . [she]
was not guilty of a felony substance
control conviction.’’ Id.
Regarding her nursing license,
Respondent stated that she ‘‘answered
‘Yes’ on the renewal of . . . [her GBN]
license to the questions regarding a
pleading Nolo Contedere [sic] and was
then placed on a two-year probationary
period in 2013 which after careful
monitoring was lifted in 2013.’’ Id.
According to her Written Statement, she
‘‘underwent psychological evaluation
and testing requested by the . . . [GBN]
which concluded that . . . [she] did not
have substance abuse problems and was
able to practice safely as a nurse.’’ Id.
Regarding the registration renewal
applications she submitted, she
admitted that, in 2015 and 2018, she
‘‘answered ‘‘no’’ to liability question 2
[sic] with the understanding because at
that time . . . [her] nursing license was
no longer under probation.’’ 5 Id.
4 Respondent explicitly ‘‘request[ed] a waiver of
a hearing.’’ RFAAX 3, at 1.
5 Respondent may have meant to refer to Liability
question ‘‘3,’’ not ‘‘2.’’
PO 00000
Frm 00164
Fmt 4703
Sfmt 4703
U:\07SEN1.SGM
50175
Respondent addressed her three false
answers to the first Liability question on
the registration renewal applications she
submitted in December, 2011, February,
2015, and January, 2018, and her two
false answers to the third Liability
question on the registration renewal
applications she submitted in 2015 and
in 2018. Id. She stated that she ‘‘did not
intentionally answer these questions to
misrepresent or give false information
for . . . [her] DEA application.’’ Id.
Respondent wrote that she ‘‘also
renewed . . . [her] Georgia nursing
license and when faced with similar
questioning ha[s] answered yes to . . .
[her] Nolo Contendere plea with an
explanation of the situation.’’ Id. She
did not attach documentary evidence to
support this assertion.
Respondent’s Written Statement states
that she ‘‘prescribe[s] medications to
patients in . . . [her] role as a nurse
practitioner’’ and that she has practiced
as a nurse, and then a nurse
practitioner, ‘‘for the past 25 years.’’ Id.
Respondent stated that she ‘‘cannot
emphasize how sorry . . . [she] is that
. . . [she has] placed [her]self in such a
position.’’ Id. at 2. She stated that she
is a mother of two and a wife, that she
has ‘‘worked hard throughout . . . [her]
life to have a successful career which
. . . [she] placed in jeopardy,’’ and that
she is ‘‘an upstanding member of . . .
[her] community and church and [has]
never abused any medications.’’ Id. The
Written Statement characterizes the
‘‘circumstances’’ as her ‘‘unwittingly
submit[ting] the wrong responses on
. . . [her] renewal applications,’’ and,
‘‘instead of a complete revocation’’ of
her registration, ‘‘appeal[s]’’ for ‘‘a
period of either probation or suspension
with monitoring and the ability to
reapply or renew’’ her registration. Id.
I find substantial record evidence that
Respondent admitted, in her Written
Statement, to writing a prescription for
herself in 2008 on a prescription pad
belonging to her collaborating
physician. Id. at 1. This wrongdoing by
Respondent is not set out in the
Government’s case. While the
Government’s case presents evidence of
one negotiated guilty plea by
Respondent arising from events in 2009,
I find substantial record evidence that
the Written Statement references ‘‘a very
grave mistake’’ of forgery by Respondent
in 2008. Compare RFAAX 4, 3–16 and
id. at 29–31 with RFAAX 3, at 1; see
also RFAAX 5, at 1 (referring to
Respondent’s ‘‘plea of guilty to the
felony criminal offense of Forgery, First
Degree in the Superior Court of Douglas
County . . . pertain[ing] to her forging
prescriptions in 2009 for pain
medication for her own use’’). I further
07SEN1
sradovich on DSKJLST7X2PROD with NOTICES
50176
Federal Register / Vol. 86, No. 170 / Tuesday, September 7, 2021 / Notices
find, based on substantial record
evidence, that the ‘‘Affidavit for Arrest’’
and the ‘‘Arrest Warrant’’ state that
Respondent presented four forged
prescriptions for filling in 2009, the year
after Respondent’s 2008 ‘‘very grave
mistake’’ forgery admission described in
her Written Statement. RFAAX 4, at 29–
31. I find substantial record evidence
that one of the instances described in
the Arrest Warrant corresponds to the
facts underlying Respondent’s
negotiated guilty plea according to the
Transcript of that plea. Id. at 9.
There is substantial fact congruity
between the evidence submitted by the
Government and Respondent’s Written
Statement. The glaring exceptions to
this substantial fact congruity are the
number of controlled substance
prescription forgeries the evidence
indicates and the number of times
Respondent pled to forging a controlled
substance prescription.
Regarding the number of controlled
substance prescription forgeries the
evidence indicates, there are significant
differences between the Written
Statement’s description of the forgery
Respondent states took place in 2008,
and the forgery underlying her 2009
guilty plea documented in the
Government’s evidence along with the
alleged forgeries described in the Arrest
Warrant. These significant differences
lead me to conclude that they describe
two different forgeries. For example, in
its description of the four purported
self-prescribed controlled substance
prescriptions, the Arrest Warrant
differentiates between brand names and
generic names for controlled substances.
See, e.g., RFAAX 4, at 31 (Arrest
Warrant description of four purported
self-prescribed controlled substance
prescriptions for ‘‘hydrocodone,’’
‘‘Vicodin,’’ ‘‘Tussionex Pennkinetic,’’
and ‘‘Vicodin’’). The Written Statement
states that the forged prescription she
wrote for herself in 2008 ‘‘was for
Vicodin which is also known as
Hydrocodone 5/500 mg.’’ RFAAX 3, at
1. The Transcript of Respondent’s guilty
plea, on the other hand, describes the
forged prescription of 2009 to have been
for ‘‘hydrocodone.’’ RFAAX 4, at 7.
While the Written Statement explains
that ‘‘Vicodin is also known as
Hydrocodone,’’ this is in direct contrast
to the record evidence in the Arrest
Warrant that provides the precise name
of the controlled substance entered on
the purportedly forged prescriptions.
Accordingly, in this context, I find that
‘‘Vicodin,’’ not ‘‘hydrocodone,’’ is a
noteworthy departure and points to two
different forgeries.
By way of further example, according
to the Written Statement, Respondent
VerDate Sep<11>2014
00:30 Sep 04, 2021
Jkt 253001
wrote the Vicodin prescription for
herself in 2008 ‘‘on a prescription pad
which belonged to . . . [her]
collaborating physician’’ and she
‘‘presented this prescription to a local
pharmacy who notified the physician
. . . [she] worked with and then
proceeded to notify the local
authorities.’’ RFAAX 3, at 1. According
to the Transcript of her 2009 guilty plea,
by contrast, the prosecutor stated that
Respondent left the employ of a medical
practice in 2008 to work for another
medical practice. RFAAX 4, at 9.
Several months after that job change, he
stated, Respondent presented a forged
hydrocodone prescription written on a
pad that belonged to the previous
employer. Id. at 9–10. The pharmacy
contacted Respondent’s new employer
and then the previous employer who
‘‘informed them that he did not write or
authorize this prescription.’’ Id. at 10.
The previous medical practice notified
law enforcement. Id. Neither
Respondent nor her Public Defender
corrected any part of these prosecutor
statements. Instead, the Public Defender
added that Respondent had retained the
prescription pad from the former
employer and forged the prescription
while at the subsequent employment.
Id. at 11. I find that the differences
between the Written Statement and the
guilty plea Transcript on these critical
points are too significant to result from
faulty memory. I further find that the
absence of any correction of those
differences by Respondent or her Public
Defender during the guilty plea
proceeding means that the 2008 forgery
described in the Written Statement and
the forgery to which Respondent pled
guilty in 2009 are not the same.
Consequently, I find that the Written
Statement describes a different forgery
than the forgery to which Respondent
pled guilty and the forgeries alleged in
the Arrest Warrant. RFAAX 4, at 31. I
consider the fact that the 2009 guilty
plea for forging a controlled substance
in the Government’s evidence was not
an isolated incident in determining the
appropriate sanction.6 Infra section IV.
Regarding the number of forgery
pleas, the Written Statement describes a
2008 nolo contendere plea for forging a
controlled substance prescription.
RFAAX 3, at 1. The conviction
described in the Government’s evidence
is a 2009 guilty plea for forging a
controlled substance prescription on
February 5, 2009. RFAAX 4, at 3–16; see
6 Although I find this fact relevant to my
determination of a sanction, there is more than
enough record evidence without it to support
revocation as a sanction based on the Government’s
prima facie case.
PO 00000
Frm 00165
Fmt 4703
Sfmt 4703
U:\07SEN1.SGM
also RFAAX 5, at 1 (referring to
Respondent’s ‘‘plea of guilty to the
felony criminal offense of Forgery, First
Degree in the Superior Court of Douglas
County . . . pertain[ing] to her forging
prescriptions in 2009 for pain
medication for her own use’’). I need not
sort out whether there were two pleas or
one plea because the OSC alleges one
felony conviction and because I am
carrying out the provisions of 21 U.S.C.
824 regarding that felony conviction
alleged in the OSC. 28 CFR 0.100(b).
Whether Respondent pled nolo
contendere to a violation in 2008 is not
an issue presented by the OSC, is not
before me for adjudication, and,
therefore, I shall not resolve it.
E. Allegation That Respondent Has Been
Convicted of a Felony Related to a
Controlled Substance (21 U.S.C.
824(a)(2))
I find that there is substantial record
evidence that Respondent, after leaving
employment at a medical practice,
retained a prescription pad of a doctor
in that medical practice. Id. at 13
(statement of Respondent’s attorney). I
find that there is substantial record
evidence that Respondent used the
prescription pad after leaving that
employment to ‘‘wr[i]te prescriptions
out for herself’’ without authorization of
the doctor to whom the prescription pad
belonged. Id. (statement of Respondent’s
attorney). I find that there is substantial
record evidence that Respondent
‘‘would have to have gone back to the
doctor to get that [prescription]
authorized prior to the time this was
done and that’s not the way it was
done.’’ Id. (statement of Respondent’s
attorney).
I find that there is substantial record
evidence that Respondent presented for
filling a controlled substance
(hydrocodone) prescription on February
5, 2009, that this prescription purported
to be issued by a doctor at her former
employment, and that this prescription
was one of the unauthorized
prescriptions Respondent wrote for
herself on the prescription pad of a
doctor at her former employment. Id. at
9.
I find that there is substantial record
evidence that the pharmacist
investigated this prescription. Id. at 10.
I find that there is substantial record
evidence that the doctor for whom
Respondent had previously worked
stated that he neither wrote nor
authorized the prescription, that this
doctor notified his practice, and that the
practice notified law enforcement. Id. I
find that there is substantial record
evidence that the prosecutor at
Respondent’s sentencing stated that
07SEN1
Federal Register / Vol. 86, No. 170 / Tuesday, September 7, 2021 / Notices
sradovich on DSKJLST7X2PROD with NOTICES
‘‘[t]here’s no evidence that there were
any other forged prescriptions presented
by . . . [Respondent].’’ Id. I find that
there is substantial record evidence that
Respondent’s attorney stated that
Respondent ‘‘retained the [prescription]
pad after she had left . . . [her prior
medical office employer’s] employ and
basically she wrote prescriptions out for
herself.’’ Id. at 13. I further find that the
‘‘Arrest Warrant’’ for Respondent
describes four allegations of Forgery in
the First Degree, including presenting
those forged prescriptions to a
pharmacy for filling, spanning February
5, 2009, through November 11, 2009. Id.
at 31. I credit the statement of
Respondent’s attorney and the items
addressed in the ‘‘Arrest Warrant’’ for
Respondent. I conclude that the
statement of Respondent’s attorney, that
Respondent ‘‘wrote prescriptions for
herself,’’ was made to ensure that all of
Respondent’s alleged criminality was
subsumed in her guilty plea. Id. at 13.
Given, among other reasons, that the
statement of Respondent’s attorney
implicated Respondent in criminality in
addition to the one instance to which
she pled guilty through a ‘‘negotiated
plea,’’ I credit the statement of
Respondent’s attorney, which I consider
in my determination of Respondent’s
appropriate sanction. Id. at 10; supra
section II.C.
Based on substantial record evidence,
I find that Respondent entered a
negotiated guilty plea to Forgery in the
First Degree, Ga. Code Ann. 16–9–1, a
Georgia felony, and that the Court
accepted her guilty plea on November
18, 2010. RFAAX 4, at 3–5, 9, 20, 26
(hydrocodone prescription); see also
RFAAX 5, at 3 (‘‘forging prescriptions’’).
I find that there is substantial record
evidence that the facts underlying
Respondent’s First-Degree Felony
conviction include her having forged
and presented for filling a controlled
substance, hydrocodone, prescription
for herself, and that the Court ordered
Respondent discharged under the
Georgia Probation for First-Offenders
Act. RFAAX 4, at 9–10; id. at 2.
F. Allegation That Respondent
Materially Falsified Registration
Renewal Applications (21 U.S.C.
824(a)(1))
I find clear, unequivocal, and
convincing evidence that, on November
18, 2010, the Honorable William H.
McClain, Superior Court Judge of
Douglas County, Georgia, found that
Respondent pled guilty to one count of
Forgery in the First Degree under
Georgia law, ‘‘freely and voluntarily,
with a full knowledge, understanding in
waiver of her rights, there’s a factual
VerDate Sep<11>2014
00:30 Sep 04, 2021
Jkt 253001
basis, and no promises, threats or force
has been used to induce’’ her plea. Id.
at 13; see also id. at 4–9. I find clear,
unequivocal, and convincing record
evidence that the facts underlying the
Georgia felony to which Respondent
pled guilty are that she forged and
presented for filling a controlled
substance (hydrocodone) prescription
made out to herself on prescription
paper belonging to a former physician
employer. Id. at 9–10, 13. I find clear,
unequivocal, and convincing record
evidence that Judge McClain accepted
her guilty plea, imposed sentence, and
treated Respondent as a first offender on
November 18, 2010. Id. at 15–16; see
also id. at 20–22. I find clear,
unequivocal, and convincing record
evidence that, on November 18, 2010,
when Judge McClain asked her before
imposing sentence if ‘‘there [is]
anything that . . . [she] would like to
say,’’ Respondent replied that she
would ‘‘[j]ust . . . enlighten people that
nurse practitioners actually do have the
authority and . . . [she] do[es] have the
authority, . . . the license to write
prescriptions for people in the State of
Georgia as in many other states, and that
is part of . . . [her] job.’’ Id. at 14–15.
I find clear, unequivocal, and
convincing record evidence that
Respondent also stated that she ‘‘did the
wrong thing in writing it for [her]self.’’
Id. at 15. I find clear, unequivocal, and
convincing record evidence that, when
Judge McClain asked her whether she
had ‘‘any sort of drug abuse problem,’’
Respondent answered, ‘‘No, I do not.’’
Id.
I find clear, unequivocal, and
convincing record evidence that, after
her felony guilty plea and sentencing on
November 18, 2010, Respondent
submitted registration renewal
applications to the Agency on December
31, 2011, on February 25, 2015, and on
January 5, 2018. RFAAX 1, at 1–10; see
also RFAAX 3, at 1–2. I find clear,
unequivocal, and convincing record
evidence that, on those three
registration renewal applications,
Respondent answered ‘‘no’’ to the first
Liability question that asked whether
she had ‘‘ever been convicted of a crime
in connection with controlled
substance(s) under state or federal law
. . . or any such action pending?’’
RFAAX 1, at 1–2, 4, 7, 10. I find clear,
unequivocal, and convincing record
evidence that Respondent admitted in
her Written Statement that she
answered ‘‘no’’ to this liability question
‘‘in . . . [her] subsequent DEA renewal
applications.’’ RFAAX 3, at 1. I find
clear, unequivocal, and convincing
record evidence that Respondent stated
PO 00000
Frm 00166
Fmt 4703
Sfmt 4703
U:\07SEN1.SGM
50177
that she provided this negative answer
in ‘‘December of 2011 . . . with the
understanding that . . . [she] was not
guilty of a felony substance control
conviction.’’ Id.
I find clear, unequivocal, and
convincing record evidence that, on
June 25, 2013, the GBN placed
Respondent’s Georgia Nurse Practitioner
license on probation for two years due
to her ‘‘fail[ure] to report her felony
conviction to the . . . [GBN] within ten
(10) days of such conviction.’’ RFAAX
5, at 3–11, citing Ga. Code Ann. 43–1–
27.7 I find clear, unequivocal, and
convincing record evidence that, after
the GBN placed her nurse practitioner
license on probation on June 25, 2013,
Respondent submitted registration
renewal applications to the Agency on
February 25, 2015 and on January 5,
2018. RFAAX 1, at 1–10; see also
RFAAX 3, at 1–2. I find clear,
unequivocal, and convincing record
evidence that, on those two registration
renewal applications, Respondent
answered ‘‘no’’ to the third Liability
question that asked whether she had
‘‘ever surrendered (for cause) or had a
state professional license or controlled
substance registration revoked,
suspended, denied, restricted, or placed
on probation, or is any such action
pending.’’ RFAAX 1, at 1–2, 4, 7, 10. I
find clear, unequivocal, and convincing
record evidence that Respondent
admitted in her Written Statement that
she answered ‘‘no’’ to this liability
question in 2015 and in 2018. RFAAX
3, at 1. I find clear, unequivocal, and
convincing record evidence that
Respondent stated that she provided
these two negative answers ‘‘with the
understanding because at that time . . .
[her] nursing license was no longer
under probation.’’ Id.
III. Discussion
A. The Controlled Substances Act
Under the Controlled Substances Act
(hereinafter, CSA), ‘‘[a] registration . . .
to . . . distribute[ ] or dispense a
controlled substance . . . may be
suspended or revoked by the Attorney
General upon a finding that the
registrant—(1) has materially falsified
any application filed pursuant to or
required by this subchapter or
7 ‘‘Any licensed individual who is convicted
under the laws of this state, the United States, or
any other state, territory, or country of a felony as
defined in paragraph (3) of subsection (a) of Code
Section 43–1–19 shall be required to notify the
appropriate licensing authority of the conviction
within ten days of the conviction. The failure of a
licensed individual to notify the appropriate
licensing authority of a conviction shall be
considered grounds for revocation of his or her
license, permit, registration, certification, or other
authorization to conduct a licensed profession.’’
07SEN1
50178
Federal Register / Vol. 86, No. 170 / Tuesday, September 7, 2021 / Notices
subchapter II; [or] (2) has been
convicted of a felony under . . . any
. . . law of the United States, or of any
State, relating to any substance defined
in this subchapter as a controlled
substance,’’ among other reasons. 21
U.S.C. 824(a). The OSC alleged material
falsification and felony conviction as
the proposed bases for revocation of
Respondent’s registration. 21 U.S.C.
824(a)(1) and (2).
sradovich on DSKJLST7X2PROD with NOTICES
B. Allegation That Respondent
Materially Falsified an Application (21
U.S.C. 824(a)(1))
As already discussed, I find clear,
unequivocal, and convincing record
evidence that Respondent submitted to
the Agency three registration renewal
applications containing a false answer
to the first Liability question. Supra
section II.F. Also, as already discussed,
I find clear, unequivocal, and
convincing record evidence that
Respondent submitted to the Agency
two registration renewal applications
containing a false answer to the third
Liability question. Id. My findings that
Respondent submitted these false
answers to the Agency stem from
Respondent’s conviction for violating a
Georgia First-Degree Felony when she
forged and presented for filling a
controlled substance prescription for
herself. Id.; infra section III.C. Further,
my fact findings directly implicate three
of the factors I am statutorily mandated
to consider as I act on applications for
registration: The applicant’s experience
in dispensing controlled substances, the
applicant’s conviction record under
Federal or State laws relating to the
dispensing of controlled substances, and
other conduct which may threaten the
public health and safety. 21 U.S.C.
823(f)(2), (3), and (5). Thus,
Respondent’s false responses on three
registration renewal applications
directly implicated my statutorilymandated analyses and decisions by
depriving me of legally relevant facts
when I evaluated those three
registration renewal applications of
Respondent. RFAAX 1, at 1–11; see also
Frank Joseph Stirlacci, M.D., 85 FR
45,229, 45,235 (2020). Accordingly, I
find, based on the CSA and the analyses
underlying multiple Supreme Court
decisions explaining ‘‘materiality,’’ that
the five false Liability question
responses Respondent submitted to the
Agency in the three registration renewal
applications at issue were material, and
that the five false responses are grounds
for the suspension or revocation of her
registration. 21 U.S.C. 824(a)(1); see
Frank Joseph Stirlacci, M.D., 85 FR
45,235.
VerDate Sep<11>2014
00:30 Sep 04, 2021
Jkt 253001
According to the Written Statement,
Respondent ‘‘responded ‘No’ to liability
question 1 with the understanding that
. . . [she] was not guilty of a felony
substance control conviction.’’ RFAAX
3, at 1. Due to the clear, unequivocal,
and convincing record evidence, I do
not credit this portion of Respondent’s
Written Statement.8 See, e.g., RFAAX 4,
at 9 and RFAAX 5, at 3; see also infra
section III.C.
Respondent’s Written Statement also
states that she ‘‘answered ‘No’ ’’ to the
third Liability question ‘‘with the
understanding because at that time . . .
[her] nursing license was no longer
under probation.’’ RFAAX 3, at 1. I do
not credit this portion of Respondent’s
Written Statement because the third
Liability question asks whether the
applicant ‘‘ever . . . had a state
professional license . . . placed on
probation.’’ RFAAX 1, at 4; id. at 10
[emphasis added].
C. Allegation That Respondent Has
Been Convicted of a Felony Related to
Any Controlled Substance (21 U.S.C.
824(a)(2))
As already discussed, I find
substantial record evidence that
Respondent entered a negotiated guilty
plea to Forgery in the First Degree, Ga.
Code Ann. 16–9–1, a Georgia felony, on
November 18, 2010.9 Supra section II.E.
I also find substantial record evidence
that the facts underlying Respondent’s
First-Degree Felony conviction include
her having forged a controlled substance
prescription for herself. Id.
Based on the facts I found in this
matter, I conclude that Respondent has
been convicted of a felony under a State
8 If Respondent intended to argue that her
negotiated guilty plea in 2010 and her treatment as
a first offender mean that she was not convicted of
a First-Degree Felony, I reject her argument. The
Agency established over thirty years ago, and
recently reiterated, that a deferred adjudication is
‘‘still a ‘conviction’ within the meaning of the . . .
[CSA] even if the proceedings are later dismissed.’’
Kimberly Maloney, N.P., 76 FR 60,922, 60,922
(2011). In reaching this conclusion, the Agency
explained that, ‘‘[a]ny other interpretation would
mean that the conviction could only be considered
between its date and the date of its subsequent
dismissal.’’ Id. (citing Edson W. Redard, M.D., 65
FR 30,616, 30,618 (2000)). The same reasoning
applies to treatment as a first offender. I also note
that the GBN Consent Order exists because
Respondent ‘‘failed to report her felony conviction
to the Board within ten (10) days of such conviction
as required by O.C.G.A. § 43–1–27.’’ RFAAX 5, at
3.
9 ‘‘A person commits the offense of forgery in the
first degree when with intent to defraud he
knowingly makes, alters, or possesses any writing
in a fictitious name or in such manner that the
writing as made or altered purports to have been
made by another person, at another time, with
different provisions, or by authority of one who did
not give such authority and utters or delivers such
writing.’’ Ga. Code Ann. § 16–9–1 (West, Westlaw
effective to June 30, 2012).
PO 00000
Frm 00167
Fmt 4703
Sfmt 4703
U:\07SEN1.SGM
law relating to a controlled substance.
21 U.S.C. 824(a)(2). First, to state the
obvious, the state of Georgia used its
First-Degree Felony Forgery statute to
prosecute and convict Respondent of
forging a controlled substance
prescription even though that Georgia
statute does not include the phrase
‘‘controlled substance’’ in its text. See
n.9. Georgia’s choice of this forgery
statute shows that Respondent was
convicted of a felony under a state law
relating to any controlled substance. 21
U.S.C. 824(a)(2).
Second, according to the Supreme
Court, the phrase ‘‘in relation to’’ is
interpreted expansively, and means
‘‘with reference to’’ or ‘‘as regards.’’
Smith v. United States, 508 U.S. 223,
237 (1993). The Smith decision
involved an offer to trade an automatic
weapon for cocaine. 508 U.S. at 225.
The decision addressed the question of
whether the exchange of a firearm for
cocaine constitutes using a firearm
‘‘during and in relation to . . . [a] drug
trafficking crime’’ within the meaning of
18 U.S.C. 924(c)(1). Id. The Supreme
Court’s analysis cited prior Supreme
Court and appellate court decisions
interpreting the phrase ‘‘in relation to’’
and concluding that the phrase should
be interpreted expansively. Id. at 237;
see, e.g., District of Columbia v. Greater
Washington Board of Trade, 506 U.S.
125, 129 (1992) (‘‘We have repeatedly
stated that a law ‘relate[s] to’ a covered
employee benefit plan . . . ‘if it has a
connection with or reference to such a
plan.’ . . . This reading is true to the
ordinary meaning of ‘relate to’ . . . and
thus gives effect to the ‘deliberately
expansive’ language chosen by
Congress.’’); United States v. Harris, 959
F.2d 246, 261 (D.C. Cir. 1992) (per
curiam) (‘‘The only limitation is that the
guns be used ‘‘in relation’’ to the drug
trafficking crime involved, which we
think requires no more than the guns
facilitate the predicate offense in some
way.’’); United States v. Phelps, 877
F.2d 28 (9th Cir. 1989) (concluding that
the situation was ‘‘unusual’’ and not
covered, the court stated that ‘‘the
phrase ‘in relation to’ is broad’’).
The Supreme Court also cited a
dictionary definition in its analysis. 508
U.S. at 237–38. It stated that
‘‘[a]ccording to Webster’s, ‘in relation to’
means ‘with reference to’ or ‘as
regards.’ ’’ Id. at 237. It concluded, thus,
that the phrase ‘‘in relation to,’’ at a
minimum, ‘‘clarifies that the firearm
must have some purpose or effect with
respect to the drug trafficking crime; its
presence or involvement cannot be the
result of accident or coincidence.’’ Id. at
238. The Court also stated that ‘‘the gun
at least must ‘facilitate[e], or ha[ve] the
07SEN1
sradovich on DSKJLST7X2PROD with NOTICES
Federal Register / Vol. 86, No. 170 / Tuesday, September 7, 2021 / Notices
potential of facilitating,’ the drug
trafficking offense.’’ Id. Applying its
analysis to the facts before it, the Court
concluded that the use of the firearm
‘‘meets any reasonable construction’’ of
‘‘in relation to’’ because the gun was ‘‘an
integral part of the transaction.’’ Id. I
apply these conclusions of the Supreme
Court as I analyze the record evidence
before me.
According to the facts I already found,
Respondent used the prescription pad of
a doctor at her former place of
employment to write a schedule II
controlled substance prescription for
herself. RFAAX 4, at 9–10 and 13. My
found facts also include that
Respondent’s registration did not have
schedule II authority. RFAAX 1, at 1. As
such, for Respondent to have any
chance of obtaining a schedule II
controlled substance from a pharmacy
by her efforts alone, she had to present
a prescription written on the
prescription pad of, and purportedly
signed by, a registrant with schedule II
authority. As my found facts show,
Respondent had already absconded with
the prescription pad of a doctor at her
former place of employment and used
that prescription pad to prescribe a
schedule II controlled substance for
herself, including forging the name of
the registrant to whom the prescription
pad belonged. RFAAX 4, at 9–10 and 13.
Under my found facts, therefore, the use
of the forged prescription was ‘‘an
integral part of the transaction.’’ Smith
v. United States, 508 U.S. at 238. Based
on the Supreme Court’s explanation of
‘‘in relation to,’’ I conclude that
Respondent’s Georgia felony forgery
conviction was ‘‘with reference to’’ and
‘‘as regards’’ a controlled substance and,
accordingly, I also conclude that
Respondent’s felony forgery conviction
satisfies the terms of 21 U.S.C. 824(a)(2).
Third, prior Agency decisions have
applied the felony conviction provision
of 21 U.S.C. 824(a)(2) to circumstances
similar to those in this matter. See, e.g.,
Samuel S. Jackson, D.D.S., 72 FR
23,848, 23,852 (2007) (conspiracy to be
an accessory after the fact); Clark G.
Triftshauser, M.D., 67 FR 71,202, 71,203
(2002) (criminal possession of a forged
instrument); Charles A. Buscema, M.D.,
59 FR 42,857, 42,858 (1994) (FirstDegree Felony conviction for falsifying
business records about the dispensing of
controlled substances, but ultimately
not finding for revocation); Lambert N.
DePompei, M.D., 49 FR 37,862, 37,863
(1984) (possession of false or forged
prescriptions are ‘‘all felony convictions
relating to controlled substances’’);
Ontario Drugs, Inc., Fullerton-Kedzie
Pharmacy, Inc., 46 FR 16,004, 16,005
(1981) (theft and forgery of controlled
VerDate Sep<11>2014
00:30 Sep 04, 2021
Jkt 253001
substance prescriptions). Consequently,
my finding that Respondent’s Georgia
forgery felony guilty plea satisfies the
terms of 21 U.S.C. 824(a)(2) is consistent
with Agency decisions issued in the last
forty years.
For all of the above reasons, I
conclude that the found facts in this
matter meet the requirements of 21
U.S.C. 824(a)(2). Accordingly, I find that
Respondent has been convicted of a
felony related to any controlled
substance. 21 U.S.C. 824(a)(2).
In sum, I find that the record evidence
supports two independent legal bases
for the suspension or revocation of
Respondent’s registration—(1) five
material falsifications in three
registration renewal applications and (2)
Respondent’s conviction of a felony
related to any controlled substance. 21
U.S.C. 824(a)(1) and (2).
IV. Sanction
Where, as here, the Government
presented two, independent bases for
the suspension or revocation of
Respondent’s registration, and
Respondent did not present evidence
rebutting either of the two bases, it is
then up to Respondent ‘‘to assure the
Administrator’’ that she ‘‘can be
entrusted with the responsibilit[ies] that
accompany registration.’’ White v. Drug
Enf’t Admin., 626 F. App’x 493, 496 (5th
Cir. 2015); see also Jones Total Health
Care Pharmacy, LLC v. Drug Enf’t
Admin., 881 F.3d 823, 830 (11th Cir.
2018) (quoting Akhtar-Zaidi v. Drug
Enf’t Admin., 841 F.3d 707, 711 (6th Cir.
2016)); MacKay v. Drug Enf’t Admin.,
664 F.3d 808, 816 (10th Cir. 2011)
(quoting Volkman v. Drug Enf’t Admin.,
567 F.3d 215, 222 (6th Cir. 2009)
quoting Hoxie v. Drug Enf’t Admin., 419
F.3d 477, 482 (6th Cir. 2005)). As the
Fifth Circuit also stated, ‘‘[s]uch
evidence includes acceptance of
responsibility and a demonstration that
the . . . [Respondent] ‘will not engage
in future misconduct.’ ’’ White v. Drug
Enf’t Admin., 626 F. App’x at 496; see
also Pharmacy Doctors Enterprises, Inc.
v. Drug Enf’t Admin., 789 F. App’x, 724,
733 (2019) (citing Jones Total Health
Care Pharmacy, LLC v. Drug Enf’t
Admin., 881 F.3d at 831 (citing MacKay
v. Drug Enf’t Admin., 664 F.3d at 820
(noting that past performance is the best
predictor of future performance and,
when a registrant has ‘‘failed to comply
with . . . [her] responsibilities in the
past, it makes sense for the agency to
consider whether . . . [she] will change
. . . [her] behavior in the future’’) and
Alra Labs., Inc. v. Drug Enf’t Admin., 54
F.3d 450, 452 (7th Cir. 1995) (‘‘An
agency rationally may conclude that
PO 00000
Frm 00168
Fmt 4703
Sfmt 4703
U:\07SEN1.SGM
50179
past performance is the best predictor of
future performance.’’))).
The Agency has decided that the
egregiousness and extent of misconduct
are significant factors in determining the
appropriate sanction. Garrett Howard
Smith, M.D., 83 FR 18,882, 18,910
(2018) (collecting cases); Samuel
Mintlow, M.D., 80 FR 3630, 3652 (2015)
(‘‘Obviously, the egregiousness and
extent of a registrant’s misconduct are
significant factors in determining the
appropriate sanction.’’). The Agency has
also considered the need to deter similar
acts in the future by Respondent and by
the community of registrants. Garrett
Howard Smith, M.D., 83 FR 18,910;
Samuel Mintlow, M.D., 80 FR 3652.
In terms of egregiousness, the five
instances of material falsification and
the felony conviction go to the heart of
the CSA: Non-compliance with the
closed regulatory system devised to
‘‘prevent the diversion of drugs from
legitimate to illicit channels’’ and not
prescribing controlled substances in
compliance with the applicable
standard of care and in the usual course
of professional practice. Gonzales v.
Raich, 545 U.S. 1, 13–14, 27 (2005).
These material falsifications and felony
conviction alone support revocation.
Further, the uncontroverted record
evidence, including Respondent’s
admissions, shows that Respondent’s
forgery of controlled substance
prescriptions for herself spanned 2008
and 2009. Supra sections II.C., II.D.,
II.E., and II.F. The record evidence
includes five instances of Respondent’s
founded (including negotiated and
admitted) or alleged forgery of a
controlled substance prescription. Id.
The admittedly and allegedly forged,
self-prescribed controlled substance
prescriptions, Vicodin/hydrocodone (4)
and Tussionex Pennkinetic (1), all
include hydrocodone, a highly abused
schedule II controlled substance. Supra
sections II.C., II.D., and II.E. In this
regard, I note Respondent’s sworn
denials of ‘‘any sort of drug abuse
problem.’’ Supra sections II.C. and II.F.
I also note, though, that Respondent’s
current registration does not authorize
her to issue schedule II controlled
substance prescriptions, and that
Respondent allegedly forged two, selfprescribed schedule II controlled
substance prescriptions in one month.
Supra sections II.A., II.C., and II.E.
Respondent’s submission does not
address acceptance of responsibility.
See supra section II.D. Indeed,
Respondent does not even acknowledge
the entirety of the OSC’s charges against
her. Her Written Statement begins by
stating that she is writing it about
‘‘material falsification of renewal
07SEN1
sradovich on DSKJLST7X2PROD with NOTICES
50180
Federal Register / Vol. 86, No. 170 / Tuesday, September 7, 2021 / Notices
applications for . . . [her] DEA license.’’
RFAAX 3, at 1. At the end of her
Written Statement, Respondent asks for
‘‘a period of either probation or
suspension with monitoring’’ ‘‘based on
the circumstances in which . . . [she]
unwittingly submitted the wrong
responses on . . . [her] renewal
applications.’’ Id. at 2. In other words,
Respondent does not even acknowledge
that the OSC also proposed the
revocation of her registration based on
21 U.S.C. 824(a)(2).
Further, the focus of her Written
Statement is that she ‘‘made a very grave
mistake which . . . [she] will forever
regret.’’ Id. at 1. It points out that she
has ‘‘undergone a lot of emotional stress
regarding the risk . . . [she] placed . . .
[her] career in.’’ Id. The Written
Statement, however, does not move
beyond the impact her wrongdoing has
on herself and her career. Id. at 1–2. It
characterizes her wrongdoing as
‘‘unwittingly submitting the wrong
responses,’’ not as violating the law and
betraying the trust of her employer and
the Agency. Id. at 2.
Respondent’s choice to submit a
Written Statement, instead of taking
advantage of her right to a hearing,
means that she cannot answer questions
about her admittedly and allegedly
forged controlled substance
prescriptions and whether she accepts
responsibility for her wrongdoing. The
areas of concern I have about her
admitted and alleged violations include
how many times she forged controlled
substance prescriptions for herself, what
controlled substances were involved,
why she forged the prescriptions, and
what she did with the controlled
substances. The areas of concern I have
about acceptance of responsibility
include whether, and for what,
Respondent unequivocally accepts
responsibility. In other words,
Respondent’s recognition of having
made a ‘‘grave mistake’’ that placed her
career in risk, the resulting experience
of ‘‘a lot of emotional stress,’’ and being
‘‘sorry’’ that she placed herself ‘‘in such
a position’’ do not constitute
unequivocal acceptance of
responsibility for her wrongdoing. All of
the areas of concern to me remain
unresolved.
In sum, the record evidence raises,
but does not answer, the extent and
degree of Respondent’s wrongdoing and
whether Respondent unequivocally
accepts responsibility for it as the
Agency requires. Jeffrey Stein, M.D., 84
FR 46,968, 46,972–73 (2019)
(unequivocal acceptance of
responsibility); Jayam Krishna-Iyer,
M.D., 74 FR 459, 463 (2009) (collecting
cases). These deficiencies are
VerDate Sep<11>2014
00:30 Sep 04, 2021
Jkt 253001
concerning. For example, they may
mean that Respondent does not
appreciate (1) the full extent of her
wrongdoing and the (2) breadth of the
harm her wrongdoing caused. I am also
left wondering what Respondent
learned from her wrongdoing, and
whether Respondent has the resources
to avoid future wrongdoing.
For all of the above reasons, it is not
reasonable for me, at this time, to trust
that Respondent will comply with all
controlled substance legal requirements
in the future.10 Alra Labs., Inc. v. Drug
Enf’t Admin., 54 F.3d at 452 (‘‘An
agency rationally may conclude that
past performance is the best predictor of
future performance.’’). Accordingly, I
shall order that Respondent’s
registration be revoked, and that all
pending applications to renew or
modify Respondent’s registration and
any pending application for a new
registration in Georgia, be denied.
Order
Pursuant to 28 CFR 0.100(b) and the
authority vested in me by 21 U.S.C.
824(a), I hereby revoke DEA Certificate
of Registration No. MS1972101 issued to
Uvienome Linda Sakor, N.P. Pursuant to
28 CFR 0.100(b) and the authority
vested in me by 21 U.S.C. 824(a) and by
21 U.S.C. 823(f), I further hereby deny
any pending application of Uvienome
Linda Sakor, N.P., to renew or modify
this registration, as well as any other
pending application of Uvienome Linda
Sakor, N.P. for registration in Georgia.
This Order is effective October 7, 2021.
Anne Milgram,
Administrator.
[FR Doc. 2021–19194 Filed 9–3–21; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. 21–13]
Lora L. Thaxton, M.D.; Decision and
Order
On March 24, 2021, the Assistant
Administrator, Diversion Control
Division, Drug Enforcement
Administration (hereinafter, DEA or
Government), issued an Order to Show
Cause (hereinafter, OSC) to Lora L.
Thaxton, M.D. (hereinafter, Respondent)
of Naples, Florida. OSC, at 1. The OSC
10 I do not consider remedial measures when a
Respondent does not unequivocally accept
responsibility. As discussed, the scope of
Respondent’s discussion of remedial efforts was
limited and, therefore, unpersuasive and not
reassuring.
PO 00000
Frm 00169
Fmt 4703
Sfmt 4703
U:\07SEN1.SGM
proposed the revocation of
Respondent’s Certificate of Registration
No. FT3429227. It alleged that
Respondent is without ‘‘authority to
handle controlled substances in Florida,
the state in which [Respondent is]
registered with DEA.’’ Id. at 2 (citing 21
U.S.C. 824(a)(3)).
Specifically, the OSC alleged that the
Florida Department of Health issued an
Order of Emergency Restriction of
License on April 14, 2020. Id. at 1. This
Order, according to the OSC, suspended
Respondent’s Florida medical license
following its findings, inter alia, that a
medical evaluator from the impaired
practitioner program for the Florida
Board of Medicine had determined that
Respondent was ‘‘unable to practice
medicine with reasonable skill and
safety to patients due to alcohol use
disorder.’’ Id. at 2. According to the
OSC, Respondent subsequently entered
into a settlement agreement with the
Florida Board of Medicine on February
5, 2021,1 under which Respondent’s
medical license would remain
suspended until she demonstrated her
ability to practice medicine with
reasonable skill and safety, submitted to
an evaluation by the impaired
practitioner program, and petitioned the
Florida Board of Medicine for
reinstatement of her medical license. Id.
The OSC notified Respondent of the
right to request a hearing on the
allegations or to submit a written
statement, while waiving the right to a
hearing, the procedures for electing each
option, and the consequences for failing
to elect either option. Id. at 2–3 (citing
21 CFR 1301.43). The OSC also notified
Respondent of the opportunity to
submit a corrective action plan. Id. at 3
(citing 21 U.S.C. 824(c)(2)(C)).
By letter dated April 29, 2021,
Respondent timely requested a hearing.2
Request for Hearing (Official
Notification). The Office of
Administrative Law Judges put the
matter on the docket and assigned it to
1 The Government’s Exhibit demonstrates that the
Florida Board of Medicine approved the settlement
agreement on April 5, 2021. See Government’s
Motion for Summary Disposition, Exhibit D, at 1–
2.
2 According to the Declaration of the lead
Diversion Investor (hereinafter, DI) assigned to this
case, the DI mailed two copies of the OSC to
Respondent on March 31, 2021. Government
Motion Exhibit 1, at 1–2. By email dated April 2,
2021, Respondent’s counsel indicated that
Respondent had received the OSC on April 2, 2021,
and would be filing a request for hearing within 30
days, as well as a proposed corrective action plan.
Request for Hearing (Emailed). Because
Respondent’s hearing request, was filed within
thirty days of the DI’s mailing the OSC on April 29,
2021, I find that the Government’s service of the
OSC was adequate and that the hearing request was
timely filed.
07SEN1
Agencies
[Federal Register Volume 86, Number 170 (Tuesday, September 7, 2021)]
[Notices]
[Pages 50173-50180]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-19194]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Uvienome Linda Sakor, N.P.; Decision and Order
I. Introduction
On June 19, 2019, the Assistant Administrator, Diversion Control
Division, Drug Enforcement Administration (hereinafter, DEA or
Government), issued an Order to Show Cause (hereinafter, OSC) to
Uvienome Sakor, N.P., also known as Uvienome Linda Sakor, N.P.,
(hereinafter, Respondent) of Douglasville, Georgia. OSC, at 1. The OSC
proposed the revocation of Respondent's Certificate of Registration No.
MS1972101, the denial of any pending applications for renewal or
modification of that registration, and the denial of any applications
for additional DEA registrations for two reasons. Id. First, it alleged
that Respondent ``materially falsified multiple renewal applications .
. . filed with the DEA.'' Id. (citing 21 U.S.C. 824(a)(1)). Second, it
alleged that Respondent ``pled guilty to a felony relating to
controlled substances.'' OSC, at 1 (citing 21 U.S.C. 824(a)(2)).
Specifically, the OSC alleged that Respondent entered a guilty plea
in Georgia Superior Court to one count of Forgery in the First Degree
``for attempting to fill a forged controlled substance prescription.''
OSC, at 2. This OSC allegation acknowledged that, under Georgia's First
Offender Act, Respondent was discharged from probation, was exonerated
of any criminal purpose, and is not considered to have a criminal
conviction. Id.
Second, the OSC alleged that Respondent entered into a Consent
Order with the Georgia Board of Nursing (hereinafter, GBN) for her
failure to report her Forgery guilty plea as required by Georgia
statute. Id. It also alleged that the Consent Order placed Respondent
on probation for two years. Id.
Third, the OSC alleged that Respondent submitted three materially
false registration renewal applications after her guilty plea because
she did not respond affirmatively to the first Liability question. Id.
at 2-3. Similarly, the OSC alleged that Respondent submitted two
materially false registration renewal applications after the beginning
of the Consent Order's probationary period because she did not respond
affirmatively to the third Liability question. Id. at 3.
Fourth, the OSC alleged that Respondent's guilty plea to the state
Forgery charge implicates 21 U.S.C. 824(a)(2). Id.
The OSC notified Respondent of the right to request a hearing on
the allegations or to submit a written statement, while waiving the
right to a hearing, the procedures for electing each option, and the
consequences for failing to elect either option. Id. at 4 (citing 21
CFR 1301.43). The OSC also notified Respondent of the opportunity to
submit a corrective action plan. OSC, at 4-5 (citing 21 U.S.C.
824(c)(2)(C)).
The Government forwarded its Request for Final Agency Action
(hereinafter, RFAA), along with the evidentiary record, to this office
on September 5, 2019. Attached to the RFAA is the Declaration of a DEA
Diversion Investigator (hereinafter, DI) that is signed and sworn to
under penalty of perjury. RFAA Exhibit (hereinafter, RFAAX) 6
(Declaration of Diversion Investigator, dated September 5, 2019
(hereinafter, DI Declaration)). The DI Declaration states that the DI
``personally served'' the OSC on Respondent at her registered location
on June 24, 2019. Id. at 3. I credit the DI's sworn statement.
Respondent waived her right to a hearing and filed a written
statement. RFAAX 3 (Respondent's Written Statement, dated July 17, 2019
(hereinafter, Written Statement)), at 1. Her Written Statement
explicitly references the OSC. Id.
Based on all of the evidence in the record, I find that the
Government's service of the OSC was legally sufficient. In addition,
based on all of the evidence in the record, I find that Respondent
timely filed her Written Statement. 21 CFR 1301.43.
I issue this Decision and Order based on the Government's
submission, which includes the Written Statement, and is the entire
record before me. 21 CFR 1301.43(e).
II. Findings of Fact
A. Respondent's DEA Controlled Substance Registration
Respondent is the holder of DEA Certificate of Registration No.
MS1972101 at the registered address of 6559 Church St., Douglasville,
GA 30134-1885. RFAAX 1 (Certification of Registration History, dated
September 4, 2019), at 1. Pursuant to this registration, Respondent is
authorized to dispense controlled substances in schedules III through V
as a MLP-nurse practitioner.\1\ Id. Respondent's registration expired
on February 28, 2021, and is in an ``active pending status.'' Id.
---------------------------------------------------------------------------
\1\ MLP means Mid-Level Practitioner. 21 CFR 1300.01(b).
---------------------------------------------------------------------------
B. The Investigation of Respondent
According to the DI assigned to this matter, ``a large number of
prescriptions that had been issued by . . . [Respondent] had been
filled'' at a pharmacy the DI was investigating, and Respondent is the
sister of the pharmacy's owner. RFAAX 6, at 1. The DI Declaration
states that Respondent ``previously had been convicted of a felony
involving forgery and that her nursing license had been placed on
probation.'' Id. According to the DI Declaration, the DI's
investigation included obtaining certified copies of records of the
Superior Court of Douglas County and of the GBN. Id. at 2; see also
infra section II.C.
C. The Government's Case
The Government's case includes five exhibits, one of which is the
Written Statement.
The first exhibit is the Certification of Registration History.
RFAAX 1. According to that Certification, Respondent submitted to the
Agency registration renewal applications on December 31, 2011, February
25, 2015, and January 5, 2018. Id. at 1. On each of the three
submissions, the Certification of Registration History states,
Respondent answered ``No'' to whether she ``has . . . ever been
convicted of a crime in connection with controlled substance(s) under
state or federal law, . . . or any such action pending.'' Id. at 1-2,
4, 7, 10. Further, on each of the three submissions, according to the
Certification of Registration History, Respondent answered ``No'' to
whether she ``has
[[Page 50174]]
. . . ever surrendered (for cause) or had a state professional license
or controlled substance registration revoked, suspended, denied,
restricted, or placed on probation, or is any such action pending.''
Id. at 2, 4, 7, 10.
The next exhibit is the OSC, RFAAX 2, and the third exhibit is the
Written Statement, RFAAX 3.
The next exhibit consists of ten documents certified by the ``Clerk
Superior/State Court'' as true and correct copies from case ``10CR00980
State of Georgia vs. Linda U. Sakor.'' \2\ RFAAX 4, at 1; see also
RFAAX 6, at 2. The first document is one page consisting of the
``Petition for Discharge of Defendant (First Offender Act)'' and the
signed ``Order of Discharge,'' dated March 20, 2012. RFAAX 4, at 2. In
this document, a probation officer states that Respondent is ``eligible
for discharge as shown by having fulfilled the term of . . . probation
and upon review of . . . [her] criminal record.'' Id. Below the
probation officer's statement, the Court's signed Order of Discharge
states that (1) Respondent is ``discharged without Court adjudication
of guilt,'' (2) the ``discharge shall completely exonerate . . .
[Respondent] of any criminal purpose,'' (3) the ``discharge shall not
affect any of . . . [Respondent's] civil rights or liberties,'' (4)
Respondent ``shall not be considered to have a criminal conviction,''
and (5) the ``discharge may not be used to disqualify a person in any
application for employment or appointment to office in either the
public or private sector by reason of criminal conviction . . . unless
otherwise provided by law.'' Id.
---------------------------------------------------------------------------
\2\ Although the certification for RFAAX 4 references ``Linda U.
Sakor,'' five of the documents in RFAAX 4 refer to ``Uvienome Linda
Sakor,'' three of the documents refer to ``Linda Sakor,'' one
document refers to ``Linda U. Sakor,'' and one document does not
refer to anyone by name. RFAAX 4, at 2 (Linda U. Sakor); id. at 3-26
(Uvienome Linda Sakor); id. at 27-30 (Linda Sakor); id. at 31 (no
name). I find substantial record evidence that all of the documents
in RFAAX 4 pertain to Respondent.
---------------------------------------------------------------------------
The second document, consisting of fifteen pages, is the
``Transcript of Proceedings'' of the criminal hearing on November 18,
2010. Id. at 3-17. The Transcript states that Respondent was present
with her attorney ``to enter a negotiated guilty plea.'' Id. at 4.
According to the Assistant District Attorney (hereinafter, ADA),
Respondent changed employers in July of 2008. Early in 2009, the ADA
stated, Respondent presented a prescription for hydrocodone,
purportedly issued by her previous employer, to be filled at a
pharmacy. Id. at 9. The ADA indicated that Respondent had forged the
prescription in the name of her previous employer. Id. at 10. He also
stated that ``[t]here's no evidence that there were any other forged
prescriptions presented'' by Respondent. Id.; see infra section II.E.
Respondent's Public Defender added that Respondent had ``retained the
[prescription] pad after she had left their employ and basically she
wrote prescriptions out for herself which basically she would have to
have gone back to the doctor to get that authorized prior to the time
this was done and that's not the way it was done.'' RFAAX 4, at 13
[emphasis added]; see infra section II.E.
When the Court invited her to speak, Respondent stated that ``nurse
practitioners actually do have the authority and . . . [she has] the
authority, . . . [has] the license to write prescriptions for people in
the State of Georgia as in many other states, and that is part of . . .
[her] job.'' RFAAX 4, at 14-15. She did not mention the controlled
substance schedule parameters, schedules III through V, of her federal
authority to issue controlled substance prescriptions. She finished by
stating that she ``did the wrong thing in writing it for . . .
[her]self.'' Id. at 15. When the Court asked her why she forged the
prescription, she stated that she ``was having severe pain and could
not make it to . . . [her] doctor's office.'' Id. When the Court asked
her, she denied having ``any sort of drug abuse problem.'' Id. The
Transcript ends with the Court imposing the recommended sentence and
treating Respondent as a first offender. Id. at 15-16.
The third document is the one-page Plea Sheet filed on November 18,
2010. Id. at 18. The Plea Sheet shows that Respondent pled guilty to
one count, that she was to undergo substance abuse counseling, that she
was fined $1,000, and that she received a sentence of five years'
probation with the possibility of four years being suspended ``after
completion of 1st year of probation successfully.'' Id.
The fourth document is the one-page Waiver of Rights, dated
November 18, 2010. Id. at 19. This document, signed by Respondent and
her attorney, lists the rights that Respondent waived by pleading
guilty. Id. Over the Court's signature, the document states that
``inquiry has been made of the . . . [Respondent] concerning the rights
listed,'' that the Court is ``satisfied there is an adequate factual
basis to support the guilty plea,'' and that the Court is satisfied
that Respondent ``is acting knowingly, freely and voluntarily and no
promise, threat or force has been used to induce the . . . [Respondent]
to enter this plea.'' Id.
The document comprising the next three pages is the ``First
Offender Treatment Order,'' the ``General Conditions of Probation,''
and the ``Special Conditions of Probation Imposed Pursuant to Code 42-
8-34.1,'' dated November 18, 2010. Id. at 20-22. This document shows
that Respondent ``negotiated'' a guilty plea to one count and was
sentenced to five years, which may be served on probation, and the
payment of a $1,000 fine. Id. at 20-21.
The sixth set of documents concerns the ``Felony Accusation'' about
Respondent. Id. at 23-26. The documents indicate that Respondent pled
guilty to one count of ``Forgery in the First Degree (O.C.G.A. 16-9-
1)'' on November 18, 2010. Id. at 23, 24, and 26. Her attorney and the
ADA signed the fully completed document along with Respondent. Id. at
26.
The next two documents, ``Entry of Appearance; and Notice of Intent
to Engage in Reciprocal Discovery'' and ``Rule 5.2(2) Certificate of
Service of Discovery,'' dated April 24, 2010, show that Respondent was
represented by counsel at the proceedings. Id. at 27-28. These
documents also show two ``unindicted'' case numbers. Id.
The ninth document is the two-page ``Affidavit for Arrest''
concerning Respondent, signed by a Douglas County Magistrate Judge on
March 30, 2010. Id. at 29-30. The first page shows a warrant in the
matter of ``The State of GA vs. [Respondent]'' charging four counts of
Forgery, a Felony in the First Degree, with bail set at $16,000. Id. at
29. The second page of the ``Affidavit for Arrest'' shows a warrant in
the matter of ``The State of GA vs. [Respondent]'' charging one count,
Theft by Taking, a misdemeanor, with bail set at $1,000. Id. at 30.
The tenth and final document is entitled ``Arrest Warrant, County
of Douglas, State of Georgia, Exhibit: A page 1 of 1'' to the Forgery
in the First Degree ``Affidavit for Arrest,'' filed on April 2010.\3\
Id. at 31. The ``Arrest Warrant'' describes four counts of Forgery in
the First Degree. The first count concerns the ``knowing,'' ``with
intent to defraud'' making of a ``certain writing in such a manner that
the writing as made purports to have been made by authority of one . .
. who did not give such authority at another time and did deliver said
writing being a prescription for Hydrocodon [sic] and Phenergan.'' Id.
The other three counts specifically concern the delivery to a pharmacy
of forged prescriptions for Vicodin and Phenergan on September 8, 2009,
Tussionex Pennkinetic on
[[Page 50175]]
November 6, 2009, and Vicodin, Ibuprofin, and Phenergan on November 11,
2009. Id.
---------------------------------------------------------------------------
\3\ The day in April is not legible. RFAAX 4, at 31.
---------------------------------------------------------------------------
The first page of the next exhibit is the Certification of the GBN,
dated July 23, 2019, concerning its Consent Order with Respondent and
the statement that ``Respondent has met the terms and conditions
outlined in this order.'' RFAAX 5, at 1. The second page is the GBN
letter to Respondent, dated July 20, 2015, advising Respondent that her
``license is unencumbered and free of the conditions imposed by'' the
Consent Order. Id. at 2.
The remaining ten pages of RFAAX 5 is the June 25, 2013 Consent
Order between Respondent and the GBN. Id. at 3-11. The first page of
the Consent Order states that Respondent pled guilty, ``[o]n or about
November 18, 2010,'' to the ``felony criminal offense of Forgery, First
Degree in the Superior Court of Douglas County.'' Id. at 3. It also
states that ``Respondent failed to report her felony conviction to the
Board within ten (10) days of such conviction as required'' by Georgia
statute. Id. Page three of the Consent Order states that, ``[u]pon the
effective date of this Consent Order, the Respondent's license to
practice as a registered professional nurse and authorization to
practice as an advanced practice nurse in the State of Georgia shall be
placed on probation for a period of two (2) years, or until lifted by
the Board.'' Id. at 5. The Consent Order specifies that ``this Consent
Order, once approved and docketed, shall constitute a public record,
evidencing disciplinary action by the Board.'' Id. at 10. The Consent
order was approved on June 20, 2013, and docketed on June 25, 2013. Id.
at 10, 3.
The last exhibit of the RFAA is the DI Declaration. RFAAX 6. In
addition to certifying some of the Government's other exhibits and
providing the origins of the investigation leading to the OSC, as
already discussed, the DI Declaration affirms that Respondent pled
guilty to one felony count ``for attempting to fill a forged controlled
substance prescription'' and ``agreed [with the GBN], among other
things, to be placed on probation for a period of two (2) years.'' Id.
at 2.
D. Respondent's Case
As already discussed, Respondent submitted a timely Written
Statement. Supra section I. In her Written Statement, Respondent stated
that she was responding to the ``material falsification of renewal
applications for . . . [her] DEA license'' by ``writ[ing] a statement
of explanation.'' \4\ RFAAX 3, at 1. Respondent began the explanation
by stating that ``[i]n the year 2008, . . . [she] made a very grave
mistake which . . . [she] will forever regret.'' Id. She elaborated,
stating that she ``wrote a prescription for . . . [her]self in 2008 on
a prescription pad which belonged to . . . [her] collaborating
physician.'' Id. The prescription, according to her Written Statement,
``was for Vicodin which is also known as Hydrocodone 5/500 mg.'' Id.
She ``did this,'' she stated, ``because . . . [she] was in severe
menstrual pain and could not make it to see . . . [her] personal
physician to prescribe this medication for . . . [her].'' Id.
Respondent wrote that she ``presented this prescription to a local
pharmacy who notified the physician . . . [she] worked with, and then
proceeded to notify the local authorities.'' Id. She stated that
``[s]ince then . . . [she has] undergone a lot of emotional stress
regarding the risk . . . [she] placed . . . [her] career in.'' Id.
---------------------------------------------------------------------------
\4\ Respondent explicitly ``request[ed] a waiver of a hearing.''
RFAAX 3, at 1.
---------------------------------------------------------------------------
According to her Written Statement, she pleaded nolo contendere and
``was sentenced under the first offender act [sic] and upon completion
of . . . [her] one-year probation was noted not to have a felony
conviction.'' Id. ``It was based on this understanding,'' Respondent
wrote, ``that . . . [she] responded to the questions in . . . [her]
subsequent DEA renewal applications.'' Id. Specifically, she admitted
that ``[i]n December of 2011 on . . . [her] DEA renewal application, .
. . [she] responded `No' to liability question 1 with the understanding
that . . . [she] was not guilty of a felony substance control
conviction.'' Id.
Regarding her nursing license, Respondent stated that she
``answered `Yes' on the renewal of . . . [her GBN] license to the
questions regarding a pleading Nolo Contedere [sic] and was then placed
on a two-year probationary period in 2013 which after careful
monitoring was lifted in 2013.'' Id. According to her Written
Statement, she ``underwent psychological evaluation and testing
requested by the . . . [GBN] which concluded that . . . [she] did not
have substance abuse problems and was able to practice safely as a
nurse.'' Id. Regarding the registration renewal applications she
submitted, she admitted that, in 2015 and 2018, she ``answered ``no''
to liability question 2 [sic] with the understanding because at that
time . . . [her] nursing license was no longer under probation.'' \5\
Id.
---------------------------------------------------------------------------
\5\ Respondent may have meant to refer to Liability question
``3,'' not ``2.''
---------------------------------------------------------------------------
Respondent addressed her three false answers to the first Liability
question on the registration renewal applications she submitted in
December, 2011, February, 2015, and January, 2018, and her two false
answers to the third Liability question on the registration renewal
applications she submitted in 2015 and in 2018. Id. She stated that she
``did not intentionally answer these questions to misrepresent or give
false information for . . . [her] DEA application.'' Id. Respondent
wrote that she ``also renewed . . . [her] Georgia nursing license and
when faced with similar questioning ha[s] answered yes to . . . [her]
Nolo Contendere plea with an explanation of the situation.'' Id. She
did not attach documentary evidence to support this assertion.
Respondent's Written Statement states that she ``prescribe[s]
medications to patients in . . . [her] role as a nurse practitioner''
and that she has practiced as a nurse, and then a nurse practitioner,
``for the past 25 years.'' Id. Respondent stated that she ``cannot
emphasize how sorry . . . [she] is that . . . [she has] placed
[her]self in such a position.'' Id. at 2. She stated that she is a
mother of two and a wife, that she has ``worked hard throughout . . .
[her] life to have a successful career which . . . [she] placed in
jeopardy,'' and that she is ``an upstanding member of . . . [her]
community and church and [has] never abused any medications.'' Id. The
Written Statement characterizes the ``circumstances'' as her
``unwittingly submit[ting] the wrong responses on . . . [her] renewal
applications,'' and, ``instead of a complete revocation'' of her
registration, ``appeal[s]'' for ``a period of either probation or
suspension with monitoring and the ability to reapply or renew'' her
registration. Id.
I find substantial record evidence that Respondent admitted, in her
Written Statement, to writing a prescription for herself in 2008 on a
prescription pad belonging to her collaborating physician. Id. at 1.
This wrongdoing by Respondent is not set out in the Government's case.
While the Government's case presents evidence of one negotiated guilty
plea by Respondent arising from events in 2009, I find substantial
record evidence that the Written Statement references ``a very grave
mistake'' of forgery by Respondent in 2008. Compare RFAAX 4, 3-16 and
id. at 29-31 with RFAAX 3, at 1; see also RFAAX 5, at 1 (referring to
Respondent's ``plea of guilty to the felony criminal offense of
Forgery, First Degree in the Superior Court of Douglas County . . .
pertain[ing] to her forging prescriptions in 2009 for pain medication
for her own use''). I further
[[Page 50176]]
find, based on substantial record evidence, that the ``Affidavit for
Arrest'' and the ``Arrest Warrant'' state that Respondent presented
four forged prescriptions for filling in 2009, the year after
Respondent's 2008 ``very grave mistake'' forgery admission described in
her Written Statement. RFAAX 4, at 29-31. I find substantial record
evidence that one of the instances described in the Arrest Warrant
corresponds to the facts underlying Respondent's negotiated guilty plea
according to the Transcript of that plea. Id. at 9.
There is substantial fact congruity between the evidence submitted
by the Government and Respondent's Written Statement. The glaring
exceptions to this substantial fact congruity are the number of
controlled substance prescription forgeries the evidence indicates and
the number of times Respondent pled to forging a controlled substance
prescription.
Regarding the number of controlled substance prescription forgeries
the evidence indicates, there are significant differences between the
Written Statement's description of the forgery Respondent states took
place in 2008, and the forgery underlying her 2009 guilty plea
documented in the Government's evidence along with the alleged
forgeries described in the Arrest Warrant. These significant
differences lead me to conclude that they describe two different
forgeries. For example, in its description of the four purported self-
prescribed controlled substance prescriptions, the Arrest Warrant
differentiates between brand names and generic names for controlled
substances. See, e.g., RFAAX 4, at 31 (Arrest Warrant description of
four purported self-prescribed controlled substance prescriptions for
``hydrocodone,'' ``Vicodin,'' ``Tussionex Pennkinetic,'' and
``Vicodin''). The Written Statement states that the forged prescription
she wrote for herself in 2008 ``was for Vicodin which is also known as
Hydrocodone 5/500 mg.'' RFAAX 3, at 1. The Transcript of Respondent's
guilty plea, on the other hand, describes the forged prescription of
2009 to have been for ``hydrocodone.'' RFAAX 4, at 7. While the Written
Statement explains that ``Vicodin is also known as Hydrocodone,'' this
is in direct contrast to the record evidence in the Arrest Warrant that
provides the precise name of the controlled substance entered on the
purportedly forged prescriptions. Accordingly, in this context, I find
that ``Vicodin,'' not ``hydrocodone,'' is a noteworthy departure and
points to two different forgeries.
By way of further example, according to the Written Statement,
Respondent wrote the Vicodin prescription for herself in 2008 ``on a
prescription pad which belonged to . . . [her] collaborating
physician'' and she ``presented this prescription to a local pharmacy
who notified the physician . . . [she] worked with and then proceeded
to notify the local authorities.'' RFAAX 3, at 1. According to the
Transcript of her 2009 guilty plea, by contrast, the prosecutor stated
that Respondent left the employ of a medical practice in 2008 to work
for another medical practice. RFAAX 4, at 9. Several months after that
job change, he stated, Respondent presented a forged hydrocodone
prescription written on a pad that belonged to the previous employer.
Id. at 9-10. The pharmacy contacted Respondent's new employer and then
the previous employer who ``informed them that he did not write or
authorize this prescription.'' Id. at 10. The previous medical practice
notified law enforcement. Id. Neither Respondent nor her Public
Defender corrected any part of these prosecutor statements. Instead,
the Public Defender added that Respondent had retained the prescription
pad from the former employer and forged the prescription while at the
subsequent employment. Id. at 11. I find that the differences between
the Written Statement and the guilty plea Transcript on these critical
points are too significant to result from faulty memory. I further find
that the absence of any correction of those differences by Respondent
or her Public Defender during the guilty plea proceeding means that the
2008 forgery described in the Written Statement and the forgery to
which Respondent pled guilty in 2009 are not the same. Consequently, I
find that the Written Statement describes a different forgery than the
forgery to which Respondent pled guilty and the forgeries alleged in
the Arrest Warrant. RFAAX 4, at 31. I consider the fact that the 2009
guilty plea for forging a controlled substance in the Government's
evidence was not an isolated incident in determining the appropriate
sanction.\6\ Infra section IV.
---------------------------------------------------------------------------
\6\ Although I find this fact relevant to my determination of a
sanction, there is more than enough record evidence without it to
support revocation as a sanction based on the Government's prima
facie case.
---------------------------------------------------------------------------
Regarding the number of forgery pleas, the Written Statement
describes a 2008 nolo contendere plea for forging a controlled
substance prescription. RFAAX 3, at 1. The conviction described in the
Government's evidence is a 2009 guilty plea for forging a controlled
substance prescription on February 5, 2009. RFAAX 4, at 3-16; see also
RFAAX 5, at 1 (referring to Respondent's ``plea of guilty to the felony
criminal offense of Forgery, First Degree in the Superior Court of
Douglas County . . . pertain[ing] to her forging prescriptions in 2009
for pain medication for her own use''). I need not sort out whether
there were two pleas or one plea because the OSC alleges one felony
conviction and because I am carrying out the provisions of 21 U.S.C.
824 regarding that felony conviction alleged in the OSC. 28 CFR
0.100(b). Whether Respondent pled nolo contendere to a violation in
2008 is not an issue presented by the OSC, is not before me for
adjudication, and, therefore, I shall not resolve it.
E. Allegation That Respondent Has Been Convicted of a Felony Related to
a Controlled Substance (21 U.S.C. 824(a)(2))
I find that there is substantial record evidence that Respondent,
after leaving employment at a medical practice, retained a prescription
pad of a doctor in that medical practice. Id. at 13 (statement of
Respondent's attorney). I find that there is substantial record
evidence that Respondent used the prescription pad after leaving that
employment to ``wr[i]te prescriptions out for herself'' without
authorization of the doctor to whom the prescription pad belonged. Id.
(statement of Respondent's attorney). I find that there is substantial
record evidence that Respondent ``would have to have gone back to the
doctor to get that [prescription] authorized prior to the time this was
done and that's not the way it was done.'' Id. (statement of
Respondent's attorney).
I find that there is substantial record evidence that Respondent
presented for filling a controlled substance (hydrocodone) prescription
on February 5, 2009, that this prescription purported to be issued by a
doctor at her former employment, and that this prescription was one of
the unauthorized prescriptions Respondent wrote for herself on the
prescription pad of a doctor at her former employment. Id. at 9.
I find that there is substantial record evidence that the
pharmacist investigated this prescription. Id. at 10. I find that there
is substantial record evidence that the doctor for whom Respondent had
previously worked stated that he neither wrote nor authorized the
prescription, that this doctor notified his practice, and that the
practice notified law enforcement. Id. I find that there is substantial
record evidence that the prosecutor at Respondent's sentencing stated
that
[[Page 50177]]
``[t]here's no evidence that there were any other forged prescriptions
presented by . . . [Respondent].'' Id. I find that there is substantial
record evidence that Respondent's attorney stated that Respondent
``retained the [prescription] pad after she had left . . . [her prior
medical office employer's] employ and basically she wrote prescriptions
out for herself.'' Id. at 13. I further find that the ``Arrest
Warrant'' for Respondent describes four allegations of Forgery in the
First Degree, including presenting those forged prescriptions to a
pharmacy for filling, spanning February 5, 2009, through November 11,
2009. Id. at 31. I credit the statement of Respondent's attorney and
the items addressed in the ``Arrest Warrant'' for Respondent. I
conclude that the statement of Respondent's attorney, that Respondent
``wrote prescriptions for herself,'' was made to ensure that all of
Respondent's alleged criminality was subsumed in her guilty plea. Id.
at 13. Given, among other reasons, that the statement of Respondent's
attorney implicated Respondent in criminality in addition to the one
instance to which she pled guilty through a ``negotiated plea,'' I
credit the statement of Respondent's attorney, which I consider in my
determination of Respondent's appropriate sanction. Id. at 10; supra
section II.C.
Based on substantial record evidence, I find that Respondent
entered a negotiated guilty plea to Forgery in the First Degree, Ga.
Code Ann. 16-9-1, a Georgia felony, and that the Court accepted her
guilty plea on November 18, 2010. RFAAX 4, at 3-5, 9, 20, 26
(hydrocodone prescription); see also RFAAX 5, at 3 (``forging
prescriptions''). I find that there is substantial record evidence that
the facts underlying Respondent's First-Degree Felony conviction
include her having forged and presented for filling a controlled
substance, hydrocodone, prescription for herself, and that the Court
ordered Respondent discharged under the Georgia Probation for First-
Offenders Act. RFAAX 4, at 9-10; id. at 2.
F. Allegation That Respondent Materially Falsified Registration Renewal
Applications (21 U.S.C. 824(a)(1))
I find clear, unequivocal, and convincing evidence that, on
November 18, 2010, the Honorable William H. McClain, Superior Court
Judge of Douglas County, Georgia, found that Respondent pled guilty to
one count of Forgery in the First Degree under Georgia law, ``freely
and voluntarily, with a full knowledge, understanding in waiver of her
rights, there's a factual basis, and no promises, threats or force has
been used to induce'' her plea. Id. at 13; see also id. at 4-9. I find
clear, unequivocal, and convincing record evidence that the facts
underlying the Georgia felony to which Respondent pled guilty are that
she forged and presented for filling a controlled substance
(hydrocodone) prescription made out to herself on prescription paper
belonging to a former physician employer. Id. at 9-10, 13. I find
clear, unequivocal, and convincing record evidence that Judge McClain
accepted her guilty plea, imposed sentence, and treated Respondent as a
first offender on November 18, 2010. Id. at 15-16; see also id. at 20-
22. I find clear, unequivocal, and convincing record evidence that, on
November 18, 2010, when Judge McClain asked her before imposing
sentence if ``there [is] anything that . . . [she] would like to say,''
Respondent replied that she would ``[j]ust . . . enlighten people that
nurse practitioners actually do have the authority and . . . [she]
do[es] have the authority, . . . the license to write prescriptions for
people in the State of Georgia as in many other states, and that is
part of . . . [her] job.'' Id. at 14-15. I find clear, unequivocal, and
convincing record evidence that Respondent also stated that she ``did
the wrong thing in writing it for [her]self.'' Id. at 15. I find clear,
unequivocal, and convincing record evidence that, when Judge McClain
asked her whether she had ``any sort of drug abuse problem,''
Respondent answered, ``No, I do not.'' Id.
I find clear, unequivocal, and convincing record evidence that,
after her felony guilty plea and sentencing on November 18, 2010,
Respondent submitted registration renewal applications to the Agency on
December 31, 2011, on February 25, 2015, and on January 5, 2018. RFAAX
1, at 1-10; see also RFAAX 3, at 1-2. I find clear, unequivocal, and
convincing record evidence that, on those three registration renewal
applications, Respondent answered ``no'' to the first Liability
question that asked whether she had ``ever been convicted of a crime in
connection with controlled substance(s) under state or federal law . .
. or any such action pending?'' RFAAX 1, at 1-2, 4, 7, 10. I find
clear, unequivocal, and convincing record evidence that Respondent
admitted in her Written Statement that she answered ``no'' to this
liability question ``in . . . [her] subsequent DEA renewal
applications.'' RFAAX 3, at 1. I find clear, unequivocal, and
convincing record evidence that Respondent stated that she provided
this negative answer in ``December of 2011 . . . with the understanding
that . . . [she] was not guilty of a felony substance control
conviction.'' Id.
I find clear, unequivocal, and convincing record evidence that, on
June 25, 2013, the GBN placed Respondent's Georgia Nurse Practitioner
license on probation for two years due to her ``fail[ure] to report her
felony conviction to the . . . [GBN] within ten (10) days of such
conviction.'' RFAAX 5, at 3-11, citing Ga. Code Ann. 43-1-27.\7\ I find
clear, unequivocal, and convincing record evidence that, after the GBN
placed her nurse practitioner license on probation on June 25, 2013,
Respondent submitted registration renewal applications to the Agency on
February 25, 2015 and on January 5, 2018. RFAAX 1, at 1-10; see also
RFAAX 3, at 1-2. I find clear, unequivocal, and convincing record
evidence that, on those two registration renewal applications,
Respondent answered ``no'' to the third Liability question that asked
whether she had ``ever surrendered (for cause) or had a state
professional license or controlled substance registration revoked,
suspended, denied, restricted, or placed on probation, or is any such
action pending.'' RFAAX 1, at 1-2, 4, 7, 10. I find clear, unequivocal,
and convincing record evidence that Respondent admitted in her Written
Statement that she answered ``no'' to this liability question in 2015
and in 2018. RFAAX 3, at 1. I find clear, unequivocal, and convincing
record evidence that Respondent stated that she provided these two
negative answers ``with the understanding because at that time . . .
[her] nursing license was no longer under probation.'' Id.
---------------------------------------------------------------------------
\7\ ``Any licensed individual who is convicted under the laws of
this state, the United States, or any other state, territory, or
country of a felony as defined in paragraph (3) of subsection (a) of
Code Section 43-1-19 shall be required to notify the appropriate
licensing authority of the conviction within ten days of the
conviction. The failure of a licensed individual to notify the
appropriate licensing authority of a conviction shall be considered
grounds for revocation of his or her license, permit, registration,
certification, or other authorization to conduct a licensed
profession.''
---------------------------------------------------------------------------
III. Discussion
A. The Controlled Substances Act
Under the Controlled Substances Act (hereinafter, CSA), ``[a]
registration . . . to . . . distribute[ ] or dispense a controlled
substance . . . may be suspended or revoked by the Attorney General
upon a finding that the registrant--(1) has materially falsified any
application filed pursuant to or required by this subchapter or
[[Page 50178]]
subchapter II; [or] (2) has been convicted of a felony under . . . any
. . . law of the United States, or of any State, relating to any
substance defined in this subchapter as a controlled substance,'' among
other reasons. 21 U.S.C. 824(a). The OSC alleged material falsification
and felony conviction as the proposed bases for revocation of
Respondent's registration. 21 U.S.C. 824(a)(1) and (2).
B. Allegation That Respondent Materially Falsified an Application (21
U.S.C. 824(a)(1))
As already discussed, I find clear, unequivocal, and convincing
record evidence that Respondent submitted to the Agency three
registration renewal applications containing a false answer to the
first Liability question. Supra section II.F. Also, as already
discussed, I find clear, unequivocal, and convincing record evidence
that Respondent submitted to the Agency two registration renewal
applications containing a false answer to the third Liability question.
Id. My findings that Respondent submitted these false answers to the
Agency stem from Respondent's conviction for violating a Georgia First-
Degree Felony when she forged and presented for filling a controlled
substance prescription for herself. Id.; infra section III.C. Further,
my fact findings directly implicate three of the factors I am
statutorily mandated to consider as I act on applications for
registration: The applicant's experience in dispensing controlled
substances, the applicant's conviction record under Federal or State
laws relating to the dispensing of controlled substances, and other
conduct which may threaten the public health and safety. 21 U.S.C.
823(f)(2), (3), and (5). Thus, Respondent's false responses on three
registration renewal applications directly implicated my statutorily-
mandated analyses and decisions by depriving me of legally relevant
facts when I evaluated those three registration renewal applications of
Respondent. RFAAX 1, at 1-11; see also Frank Joseph Stirlacci, M.D., 85
FR 45,229, 45,235 (2020). Accordingly, I find, based on the CSA and the
analyses underlying multiple Supreme Court decisions explaining
``materiality,'' that the five false Liability question responses
Respondent submitted to the Agency in the three registration renewal
applications at issue were material, and that the five false responses
are grounds for the suspension or revocation of her registration. 21
U.S.C. 824(a)(1); see Frank Joseph Stirlacci, M.D., 85 FR 45,235.
According to the Written Statement, Respondent ``responded `No' to
liability question 1 with the understanding that . . . [she] was not
guilty of a felony substance control conviction.'' RFAAX 3, at 1. Due
to the clear, unequivocal, and convincing record evidence, I do not
credit this portion of Respondent's Written Statement.\8\ See, e.g.,
RFAAX 4, at 9 and RFAAX 5, at 3; see also infra section III.C.
---------------------------------------------------------------------------
\8\ If Respondent intended to argue that her negotiated guilty
plea in 2010 and her treatment as a first offender mean that she was
not convicted of a First-Degree Felony, I reject her argument. The
Agency established over thirty years ago, and recently reiterated,
that a deferred adjudication is ``still a `conviction' within the
meaning of the . . . [CSA] even if the proceedings are later
dismissed.'' Kimberly Maloney, N.P., 76 FR 60,922, 60,922 (2011). In
reaching this conclusion, the Agency explained that, ``[a]ny other
interpretation would mean that the conviction could only be
considered between its date and the date of its subsequent
dismissal.'' Id. (citing Edson W. Redard, M.D., 65 FR 30,616, 30,618
(2000)). The same reasoning applies to treatment as a first
offender. I also note that the GBN Consent Order exists because
Respondent ``failed to report her felony conviction to the Board
within ten (10) days of such conviction as required by O.C.G.A.
Sec. 43-1-27.'' RFAAX 5, at 3.
---------------------------------------------------------------------------
Respondent's Written Statement also states that she ``answered `No'
'' to the third Liability question ``with the understanding because at
that time . . . [her] nursing license was no longer under probation.''
RFAAX 3, at 1. I do not credit this portion of Respondent's Written
Statement because the third Liability question asks whether the
applicant ``ever . . . had a state professional license . . . placed on
probation.'' RFAAX 1, at 4; id. at 10 [emphasis added].
C. Allegation That Respondent Has Been Convicted of a Felony Related to
Any Controlled Substance (21 U.S.C. 824(a)(2))
As already discussed, I find substantial record evidence that
Respondent entered a negotiated guilty plea to Forgery in the First
Degree, Ga. Code Ann. 16-9-1, a Georgia felony, on November 18,
2010.\9\ Supra section II.E. I also find substantial record evidence
that the facts underlying Respondent's First-Degree Felony conviction
include her having forged a controlled substance prescription for
herself. Id.
---------------------------------------------------------------------------
\9\ ``A person commits the offense of forgery in the first
degree when with intent to defraud he knowingly makes, alters, or
possesses any writing in a fictitious name or in such manner that
the writing as made or altered purports to have been made by another
person, at another time, with different provisions, or by authority
of one who did not give such authority and utters or delivers such
writing.'' Ga. Code Ann. Sec. 16-9-1 (West, Westlaw effective to
June 30, 2012).
---------------------------------------------------------------------------
Based on the facts I found in this matter, I conclude that
Respondent has been convicted of a felony under a State law relating to
a controlled substance. 21 U.S.C. 824(a)(2). First, to state the
obvious, the state of Georgia used its First-Degree Felony Forgery
statute to prosecute and convict Respondent of forging a controlled
substance prescription even though that Georgia statute does not
include the phrase ``controlled substance'' in its text. See n.9.
Georgia's choice of this forgery statute shows that Respondent was
convicted of a felony under a state law relating to any controlled
substance. 21 U.S.C. 824(a)(2).
Second, according to the Supreme Court, the phrase ``in relation
to'' is interpreted expansively, and means ``with reference to'' or
``as regards.'' Smith v. United States, 508 U.S. 223, 237 (1993). The
Smith decision involved an offer to trade an automatic weapon for
cocaine. 508 U.S. at 225. The decision addressed the question of
whether the exchange of a firearm for cocaine constitutes using a
firearm ``during and in relation to . . . [a] drug trafficking crime''
within the meaning of 18 U.S.C. 924(c)(1). Id. The Supreme Court's
analysis cited prior Supreme Court and appellate court decisions
interpreting the phrase ``in relation to'' and concluding that the
phrase should be interpreted expansively. Id. at 237; see, e.g.,
District of Columbia v. Greater Washington Board of Trade, 506 U.S.
125, 129 (1992) (``We have repeatedly stated that a law `relate[s] to'
a covered employee benefit plan . . . `if it has a connection with or
reference to such a plan.' . . . This reading is true to the ordinary
meaning of `relate to' . . . and thus gives effect to the `deliberately
expansive' language chosen by Congress.''); United States v. Harris,
959 F.2d 246, 261 (D.C. Cir. 1992) (per curiam) (``The only limitation
is that the guns be used ``in relation'' to the drug trafficking crime
involved, which we think requires no more than the guns facilitate the
predicate offense in some way.''); United States v. Phelps, 877 F.2d 28
(9th Cir. 1989) (concluding that the situation was ``unusual'' and not
covered, the court stated that ``the phrase `in relation to' is
broad'').
The Supreme Court also cited a dictionary definition in its
analysis. 508 U.S. at 237-38. It stated that ``[a]ccording to
Webster's, `in relation to' means `with reference to' or `as regards.'
'' Id. at 237. It concluded, thus, that the phrase ``in relation to,''
at a minimum, ``clarifies that the firearm must have some purpose or
effect with respect to the drug trafficking crime; its presence or
involvement cannot be the result of accident or coincidence.'' Id. at
238. The Court also stated that ``the gun at least must `facilitate[e],
or ha[ve] the
[[Page 50179]]
potential of facilitating,' the drug trafficking offense.'' Id.
Applying its analysis to the facts before it, the Court concluded that
the use of the firearm ``meets any reasonable construction'' of ``in
relation to'' because the gun was ``an integral part of the
transaction.'' Id. I apply these conclusions of the Supreme Court as I
analyze the record evidence before me.
According to the facts I already found, Respondent used the
prescription pad of a doctor at her former place of employment to write
a schedule II controlled substance prescription for herself. RFAAX 4,
at 9-10 and 13. My found facts also include that Respondent's
registration did not have schedule II authority. RFAAX 1, at 1. As
such, for Respondent to have any chance of obtaining a schedule II
controlled substance from a pharmacy by her efforts alone, she had to
present a prescription written on the prescription pad of, and
purportedly signed by, a registrant with schedule II authority. As my
found facts show, Respondent had already absconded with the
prescription pad of a doctor at her former place of employment and used
that prescription pad to prescribe a schedule II controlled substance
for herself, including forging the name of the registrant to whom the
prescription pad belonged. RFAAX 4, at 9-10 and 13. Under my found
facts, therefore, the use of the forged prescription was ``an integral
part of the transaction.'' Smith v. United States, 508 U.S. at 238.
Based on the Supreme Court's explanation of ``in relation to,'' I
conclude that Respondent's Georgia felony forgery conviction was ``with
reference to'' and ``as regards'' a controlled substance and,
accordingly, I also conclude that Respondent's felony forgery
conviction satisfies the terms of 21 U.S.C. 824(a)(2).
Third, prior Agency decisions have applied the felony conviction
provision of 21 U.S.C. 824(a)(2) to circumstances similar to those in
this matter. See, e.g., Samuel S. Jackson, D.D.S., 72 FR 23,848, 23,852
(2007) (conspiracy to be an accessory after the fact); Clark G.
Triftshauser, M.D., 67 FR 71,202, 71,203 (2002) (criminal possession of
a forged instrument); Charles A. Buscema, M.D., 59 FR 42,857, 42,858
(1994) (First-Degree Felony conviction for falsifying business records
about the dispensing of controlled substances, but ultimately not
finding for revocation); Lambert N. DePompei, M.D., 49 FR 37,862,
37,863 (1984) (possession of false or forged prescriptions are ``all
felony convictions relating to controlled substances''); Ontario Drugs,
Inc., Fullerton-Kedzie Pharmacy, Inc., 46 FR 16,004, 16,005 (1981)
(theft and forgery of controlled substance prescriptions).
Consequently, my finding that Respondent's Georgia forgery felony
guilty plea satisfies the terms of 21 U.S.C. 824(a)(2) is consistent
with Agency decisions issued in the last forty years.
For all of the above reasons, I conclude that the found facts in
this matter meet the requirements of 21 U.S.C. 824(a)(2). Accordingly,
I find that Respondent has been convicted of a felony related to any
controlled substance. 21 U.S.C. 824(a)(2).
In sum, I find that the record evidence supports two independent
legal bases for the suspension or revocation of Respondent's
registration--(1) five material falsifications in three registration
renewal applications and (2) Respondent's conviction of a felony
related to any controlled substance. 21 U.S.C. 824(a)(1) and (2).
IV. Sanction
Where, as here, the Government presented two, independent bases for
the suspension or revocation of Respondent's registration, and
Respondent did not present evidence rebutting either of the two bases,
it is then up to Respondent ``to assure the Administrator'' that she
``can be entrusted with the responsibilit[ies] that accompany
registration.'' White v. Drug Enf't Admin., 626 F. App'x 493, 496 (5th
Cir. 2015); see also Jones Total Health Care Pharmacy, LLC v. Drug
Enf't Admin., 881 F.3d 823, 830 (11th Cir. 2018) (quoting Akhtar-Zaidi
v. Drug Enf't Admin., 841 F.3d 707, 711 (6th Cir. 2016)); MacKay v.
Drug Enf't Admin., 664 F.3d 808, 816 (10th Cir. 2011) (quoting Volkman
v. Drug Enf't Admin., 567 F.3d 215, 222 (6th Cir. 2009) quoting Hoxie
v. Drug Enf't Admin., 419 F.3d 477, 482 (6th Cir. 2005)). As the Fifth
Circuit also stated, ``[s]uch evidence includes acceptance of
responsibility and a demonstration that the . . . [Respondent] `will
not engage in future misconduct.' '' White v. Drug Enf't Admin., 626 F.
App'x at 496; see also Pharmacy Doctors Enterprises, Inc. v. Drug Enf't
Admin., 789 F. App'x, 724, 733 (2019) (citing Jones Total Health Care
Pharmacy, LLC v. Drug Enf't Admin., 881 F.3d at 831 (citing MacKay v.
Drug Enf't Admin., 664 F.3d at 820 (noting that past performance is the
best predictor of future performance and, when a registrant has
``failed to comply with . . . [her] responsibilities in the past, it
makes sense for the agency to consider whether . . . [she] will change
. . . [her] behavior in the future'') and Alra Labs., Inc. v. Drug
Enf't Admin., 54 F.3d 450, 452 (7th Cir. 1995) (``An agency rationally
may conclude that past performance is the best predictor of future
performance.''))).
The Agency has decided that the egregiousness and extent of
misconduct are significant factors in determining the appropriate
sanction. Garrett Howard Smith, M.D., 83 FR 18,882, 18,910 (2018)
(collecting cases); Samuel Mintlow, M.D., 80 FR 3630, 3652 (2015)
(``Obviously, the egregiousness and extent of a registrant's misconduct
are significant factors in determining the appropriate sanction.'').
The Agency has also considered the need to deter similar acts in the
future by Respondent and by the community of registrants. Garrett
Howard Smith, M.D., 83 FR 18,910; Samuel Mintlow, M.D., 80 FR 3652.
In terms of egregiousness, the five instances of material
falsification and the felony conviction go to the heart of the CSA:
Non-compliance with the closed regulatory system devised to ``prevent
the diversion of drugs from legitimate to illicit channels'' and not
prescribing controlled substances in compliance with the applicable
standard of care and in the usual course of professional practice.
Gonzales v. Raich, 545 U.S. 1, 13-14, 27 (2005). These material
falsifications and felony conviction alone support revocation.
Further, the uncontroverted record evidence, including Respondent's
admissions, shows that Respondent's forgery of controlled substance
prescriptions for herself spanned 2008 and 2009. Supra sections II.C.,
II.D., II.E., and II.F. The record evidence includes five instances of
Respondent's founded (including negotiated and admitted) or alleged
forgery of a controlled substance prescription. Id. The admittedly and
allegedly forged, self-prescribed controlled substance prescriptions,
Vicodin/hydrocodone (4) and Tussionex Pennkinetic (1), all include
hydrocodone, a highly abused schedule II controlled substance. Supra
sections II.C., II.D., and II.E. In this regard, I note Respondent's
sworn denials of ``any sort of drug abuse problem.'' Supra sections
II.C. and II.F. I also note, though, that Respondent's current
registration does not authorize her to issue schedule II controlled
substance prescriptions, and that Respondent allegedly forged two,
self-prescribed schedule II controlled substance prescriptions in one
month. Supra sections II.A., II.C., and II.E.
Respondent's submission does not address acceptance of
responsibility. See supra section II.D. Indeed, Respondent does not
even acknowledge the entirety of the OSC's charges against her. Her
Written Statement begins by stating that she is writing it about
``material falsification of renewal
[[Page 50180]]
applications for . . . [her] DEA license.'' RFAAX 3, at 1. At the end
of her Written Statement, Respondent asks for ``a period of either
probation or suspension with monitoring'' ``based on the circumstances
in which . . . [she] unwittingly submitted the wrong responses on . . .
[her] renewal applications.'' Id. at 2. In other words, Respondent does
not even acknowledge that the OSC also proposed the revocation of her
registration based on 21 U.S.C. 824(a)(2).
Further, the focus of her Written Statement is that she ``made a
very grave mistake which . . . [she] will forever regret.'' Id. at 1.
It points out that she has ``undergone a lot of emotional stress
regarding the risk . . . [she] placed . . . [her] career in.'' Id. The
Written Statement, however, does not move beyond the impact her
wrongdoing has on herself and her career. Id. at 1-2. It characterizes
her wrongdoing as ``unwittingly submitting the wrong responses,'' not
as violating the law and betraying the trust of her employer and the
Agency. Id. at 2.
Respondent's choice to submit a Written Statement, instead of
taking advantage of her right to a hearing, means that she cannot
answer questions about her admittedly and allegedly forged controlled
substance prescriptions and whether she accepts responsibility for her
wrongdoing. The areas of concern I have about her admitted and alleged
violations include how many times she forged controlled substance
prescriptions for herself, what controlled substances were involved,
why she forged the prescriptions, and what she did with the controlled
substances. The areas of concern I have about acceptance of
responsibility include whether, and for what, Respondent unequivocally
accepts responsibility. In other words, Respondent's recognition of
having made a ``grave mistake'' that placed her career in risk, the
resulting experience of ``a lot of emotional stress,'' and being
``sorry'' that she placed herself ``in such a position'' do not
constitute unequivocal acceptance of responsibility for her wrongdoing.
All of the areas of concern to me remain unresolved.
In sum, the record evidence raises, but does not answer, the extent
and degree of Respondent's wrongdoing and whether Respondent
unequivocally accepts responsibility for it as the Agency requires.
Jeffrey Stein, M.D., 84 FR 46,968, 46,972-73 (2019) (unequivocal
acceptance of responsibility); Jayam Krishna-Iyer, M.D., 74 FR 459, 463
(2009) (collecting cases). These deficiencies are concerning. For
example, they may mean that Respondent does not appreciate (1) the full
extent of her wrongdoing and the (2) breadth of the harm her wrongdoing
caused. I am also left wondering what Respondent learned from her
wrongdoing, and whether Respondent has the resources to avoid future
wrongdoing.
For all of the above reasons, it is not reasonable for me, at this
time, to trust that Respondent will comply with all controlled
substance legal requirements in the future.\10\ Alra Labs., Inc. v.
Drug Enf't Admin., 54 F.3d at 452 (``An agency rationally may conclude
that past performance is the best predictor of future performance.'').
Accordingly, I shall order that Respondent's registration be revoked,
and that all pending applications to renew or modify Respondent's
registration and any pending application for a new registration in
Georgia, be denied.
---------------------------------------------------------------------------
\10\ I do not consider remedial measures when a Respondent does
not unequivocally accept responsibility. As discussed, the scope of
Respondent's discussion of remedial efforts was limited and,
therefore, unpersuasive and not reassuring.
---------------------------------------------------------------------------
Order
Pursuant to 28 CFR 0.100(b) and the authority vested in me by 21
U.S.C. 824(a), I hereby revoke DEA Certificate of Registration No.
MS1972101 issued to Uvienome Linda Sakor, N.P. Pursuant to 28 CFR
0.100(b) and the authority vested in me by 21 U.S.C. 824(a) and by 21
U.S.C. 823(f), I further hereby deny any pending application of
Uvienome Linda Sakor, N.P., to renew or modify this registration, as
well as any other pending application of Uvienome Linda Sakor, N.P. for
registration in Georgia. This Order is effective October 7, 2021.
Anne Milgram,
Administrator.
[FR Doc. 2021-19194 Filed 9-3-21; 8:45 am]
BILLING CODE 4410-09-P